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Abstract
Vitamin D is essential to optimizing health; vitamin D deficiency (VDD) can increase
risk of hypertension, cardiovascular disease, and insulin resistance. VDD occurs when
individuals do not receive sufficient oral intake or obtain adequate sun exposure.
Previous researchers indicated there is a relationship between VDD and depression, while
others have indicated there is no relationship. The purpose of this study was to examine
the relationship between vitamin D levels and depression, and how this relationship
might be moderated by an individual’s demographic characteristics (gender, age,
smoking status, or marital status). This study was a quantitative data analysis of archival
data from the 2005-2006 National Health and Nutrition Examination Survey. The Health
Belief Model was the theoretical framework. An ex-post facto exploratory analysis was
used to test 2,623 adults located throughout the United States. Employing moderated
multiple regression, a significant relationship was found between vitamin D levels and
depression (p. < .001); however, the relationship was not moderated by demographic
characteristics (gender, age, smoking status, or marital status). This study supports prior
researchers who affirmed a correlation between vitamin D levels and depression. Given
the definitive findings, practitioners should continue to recommend intake of vitamin D
to individuals not meeting recommended daily dosages, but recommendations should not
be based on gender, age, smoking status, or marital status. Understanding the connection
between VDD and depression provides a basis on which to foster positive social change
at the individual, family, organizational, and societal level.

Assessment of Vitamin D Levels and Depression Among Adults in the United States
by
Troy Jean-Luc Owens

MPH, Walden University, 2011
BS, University of California, San Diego, 2000

Dissertation Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Philosophy
Public Health

Walden University
March 2015

Dedication
I dedicate this achievement to my wife and best friend, Dimar. I also wish to
dedicate this dissertation to my daughters, Giselle and Isabelle. It is because of your
unconditional love, encouragement, and patience that this doctorate of philosophy was
attained. I am incredibly, indescribably fortunate and grateful to have each of you in my
life.

Acknowledgements
I sincerely appreciate the contributions of all individuals who have supported me
in achieving this milestone. I am thankful for the dedicated guidance and mentorship of
my committee chair, Dr. John Nemecek, and committee member, Dr. Raymond Panas.
Also, I thank my sister, Stephanie Owens, and my in-laws, Dr. Marcos and Digna
Borrero, for their steadfast support and prayers. Further, I am grateful to my mother-inlaw for her loving, thoughtful, and sacrificial support throughout the process. Finally, I
thank my dear parents, Dr. Powell and Regine Owens, for instilling the importance of
family, community, integrity, education, and most importantly, love.

Table of Contents
Table of Tables .................................................................................................................. vi	
  
Chapter 1: Introduction to the Study.................................................................................. 1	
  
Background of the Study .............................................................................................. 1	
  
Problem Statement ........................................................................................................ 2	
  
Purpose.......................................................................................................................... 3	
  
Research Question ........................................................................................................ 4	
  
Nature of the Study ....................................................................................................... 4	
  
Assumptions............................................................................................................ 5	
  
Scope and Delimitations ......................................................................................... 6	
  
Limitations .............................................................................................................. 7	
  
Theoretical Framework................................................................................................. 8	
  
Significance ................................................................................................................ 10	
  
Definitions .................................................................................................................. 11	
  
Summary ..................................................................................................................... 12	
  
Chapter 2: Literature Review........................................................................................... 14	
  
Introduction................................................................................................................. 14	
  
Literature Search Strategy .......................................................................................... 15	
  
Theoretical Framework............................................................................................... 16	
  
Association between Depression and Vitamin D Deficiency ..................................... 17	
  
Consequences of Vitamin D Deficiency............................................................... 17	
  
Variables Impacting the Relationship between Depression and Vitamin D
Deficiency ............................................................................................................. 18	
  
i

Depression .................................................................................................................. 21	
  
Signs and Symptoms of Depression ..................................................................... 23	
  
Causes of Depression............................................................................................ 23	
  
Health Risks Associated with Depression .................................................................. 24	
  
Treatment .............................................................................................................. 25	
  
Risk of Recurrence................................................................................................ 26	
  
Vitamin D ................................................................................................................... 27	
  
Vitamin D and Brain Function.................................................................................... 29	
  
Benefits of Vitamin D........................................................................................... 31	
  
Vitamin D Deficiency ........................................................................................... 31	
  
Health Risk and Treatment for Vitamin D Deficiency ......................................... 33	
  
The Role of Public Health Education ......................................................................... 34	
  
Mental Health ....................................................................................................... 34	
  
Vitamin D ................................................................................................................... 37	
  
Summary ..................................................................................................................... 41	
  
Chapter 3: Methodology ................................................................................................... 43	
  
Introduction................................................................................................................. 43	
  
Research Design and Rationale .................................................................................. 43	
  
Research Questions............................................................................................... 45	
  
Operational Model ................................................................................................ 45	
  
Population, Sample, and Sampling Methodology ...................................................... 46	
  
Population ............................................................................................................. 46	
  
Sample .................................................................................................................. 46	
  
ii

Sampling Methodology......................................................................................... 47	
  
Power Analysis ..................................................................................................... 47	
  
Procedures................................................................................................................... 47	
  
Instrumentation ........................................................................................................... 48	
  
Operationalization of Variables .................................................................................. 51	
  
Vitamin D Levels.................................................................................................. 52	
  
Depression ............................................................................................................ 52	
  
Gender................................................................................................................... 54	
  
Age........................................................................................................................ 54	
  
Smoking Status ..................................................................................................... 54	
  
Marital Status ........................................................................................................ 55	
  
Data Analysis Plan...................................................................................................... 55	
  
Threats to Validity ...................................................................................................... 56	
  
Methodological Limitation ................................................................................... 57	
  
Ethical Procedures ...................................................................................................... 58	
  
Summary ..................................................................................................................... 61	
  
Chapter 4: Results ............................................................................................................. 62	
  
Introduction................................................................................................................. 62	
  
Data Collection ........................................................................................................... 62	
  
Population and Sample ......................................................................................... 63	
  
Data Analysis Procedure............................................................................................. 64	
  
Analysis of Research Question 1 .......................................................................... 65	
  
ANOVA Analyses ...................................................................................................... 73	
  
iii

ANOVA Analysis 1 .............................................................................................. 73	
  
ANOVA Analysis 2 .............................................................................................. 74	
  
Results Analysis 1................................................................................................. 75	
  
Results Analysis 2................................................................................................. 77	
  
Results Analysis 3................................................................................................. 78	
  
Results Analysis 4................................................................................................. 79	
  
Summary ..................................................................................................................... 81	
  
Chapter 5: Discussion ....................................................................................................... 83	
  
Introduction................................................................................................................. 83	
  
Summary of Findings.................................................................................................. 86	
  
Results of Research Hypothesis 1......................................................................... 86	
  
Strengths of the Study................................................................................................. 87	
  
Limitations of the Study ............................................................................................. 88	
  
Generalizability..................................................................................................... 88	
  
Validity ................................................................................................................. 88	
  
Reliability.............................................................................................................. 89	
  
Recommendations....................................................................................................... 91	
  
Recommendations for Future Research ................................................................ 91	
  
Recommendations for Practice ............................................................................. 92	
  
Implications for Positive Social Change..................................................................... 94	
  
Conclusion .................................................................................................................. 95	
  
References......................................................................................................................... 98	
  
Appendix A..................................................................................................................... 119	
  
iv

Appendix B ..................................................................................................................... 121	
  

v

Table of Tables
Table 1. Frequency and Percent Statistics of Participants’ Gender and Age ................... 66	
  
Table 2. Frequency and Percent Statistics of Participants’ Marital Status and Smoke
Status................................................................................................................................. 67	
  
Table 3. Descriptive Statistics of the Criterion and Predictor Variables .......................... 68	
  
Table 4. Skewness and Kurtosis Statistics of the Criterion and Predictor Variables ....... 73	
  
Table 5. Model Summary of ANOVA Analysis of Analysis 1 ........................................ 74	
  
Table 6. Model Summary of ANOVA Analysis of Analysis 2 ........................................ 75	
  
Table 7. Model Summary of Regression Analysis ........................................................... 76	
  
Table 8. Model Summary Generated from Moderated Multiple Regression Analysis 1 . 77	
  
Table 9. Model Summary Generated from Moderated Multiple Regression Analysis 2 . 78	
  
Table 10. Model Summary Generated from Moderated Multiple Regression Analysis 3 79	
  
Table 11. Model Summary Generated from Moderated Multiple Regression Analysis 4 80	
  
Table 12. Final Model Summary Generated from Sequential Multiple Regression
Analysis ............................................................................................................................ 81	
  
Table 13. Summary of Results for Analyses 1-4 .............................................................. 82	
  

vi

1
Chapter 1: Introduction to the Study
Background of the Study
Vitamin D deficiency (VDD) can affect individuals of any age, race, or gender
(Lappe, 2011). Vitamin D receptors exist in almost all human tissue and cells, and
sufficient levels are important for optimum operation of those tissues and cells (Lappe,
2011). VDD can lead to multiple health consequences, including a major mood disorder
(e.g., depressed mood, abated interest, altered appetite, sleep disorder, exhaustion,
psychomotor disorder, feelings of inadequacy, inability to make decisions, and suicidal
speculation; Wilkins, Sheline, Roe, Birge, & Morris, 2006).
At-risk groups for VDD include the elderly, women, and those with a history of
chronic illness (e.g., diabetes, heart attack, stroke, and/or cancer; Hoang et al., 2011).
These same at risk groups are also at risk for depression (Dong, Zhang, Tong, & Qin,
2012; Gross, Gallo, & Eaton, 2010; Pan et al., 2011). Despite considerable research
linking VDD with depression, the evidence remains controversial, because some
researchers have concluded that there is no relationship between VDD and depression
(Bertone-Johnson, 2009; Harris & Dawson-Hughes, 1993; Kwasky, & Groh, 2012;
Schneider, Weber, Frensch, Stein, & Fritze, 2000). Results have been inconsistent and
inconclusive (Bertone-Johnson, 2009). Additional investigation is warranted to better
understand whether there is a relationship between these two conditions.
According Bertone-Johnson (2009), confounding variables often interfere in
research focusing on vitamin D and depression due to multiple factors (e.g., aging, period
of time living indoors, geographic coordinates, physical exercise, weight, and drug use)
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that can alter 25(OH)D (a prehormone that is formed in the liver through hydroxylation
of vitamin D3; cholecalciferol) levels, many of which cannot be controlled. Further, the
epidemiological evidence on whether hypovitaminosis D (i.e., deficiency of vitamin D) is
associated with depression remains limited (McCann & Ames, 2008; Milaneschi et al.,
2013). More investigations are needed to determine if preventive or treatment
interventions for depression should be coupled with preventing hypovitaminosis D as a
cost-effective form of treatment (Holick, 2004; Milaneschi et al., 2013).
Such investigation is necessary because both VDD and depression are two major
public health concerns that have significant implications for those who suffer from either
condition. Whether the two health conditions are associated with each other requires
further research. Addressing VDD and depression via cost-effective, safe, and effective
public health measures may be an appropriate means to lowering the rates of both adverse
health conditions. This study was designed to contribute to the existing base of
scholarship in this area. This chapter includes an introduction to the study, including the
problem and purpose of the research, the guiding research questions, and the nature of the
study. The theoretical framework is also presented, along with relevant definitions that
will be used throughout the study.
Problem Statement
The direction and result of common chronic conditions (e.g., arthritis, asthma,
cardiovascular disease, cancer, diabetes, and obesity) could be adversely impacted by
depression (Centers for Disease Control and Prevention [CDC], 2012a). If depression is
left untreated, job absence, low job performance, and diminished work productivity can
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result (CDC, 2012a). Similarly, vitamin D levels are often examined during routine
physical exams and VDD is linked to risk for multiple health issues (Grineva, Karonova,
Micheeva, Belyaeva, & Nikitina, 2013). For instance, vitamin D deficiency is a relevant
and significant risk factor implicated in many health conditions such as cardiovascular
disease, type 2 diabetes, obesity, rickets, osteomalacia, and progressive renal function
loss (de Borst et al., 2011; Grineva et al., 2013).
Given the significant health risks that are associated with VDD and depression, it
is important to fully understand the potential correlation between the two. However, the
association between VDD with depression remains limited (McCann & Ames, 2008;
Milaneschi et al., 2013). There is a possibility that the inconsistencies in the prior
research stem from a failure to identify any possible differences in this relationship by
gender, age, smoking status, or marital status. Without such understanding, prevention
and intervention strategies designed to address both conditions will be limited. The
research problem addressed in this study is whether or not vitamin D levels effect
depression, and if covariates (gender, age, smoking status, or marital status) have an
impact.
Purpose
I examined the relationship between vitamin D levels and depression, and how
this relationship might be moderated by an individual’s demographic characteristics
(gender, age, smoking status, or marital status). There is evidence that vitamin D is
essential to optimizing health and preventing disease (Bertone-Johnson, 2009). There is a
need to determine if VDD is physiologically related to the occurrence of depression
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(Bertone-Johnson, 2009). The intent of this study was to explore whether there is a
relationship between vitamin D levels and depression, and how this might be moderated
by an individual’s demographic characteristics such as gender, age, smoking status, or
marital status.
Research Question
To guide this quantitative study, one research question was used. The variables of
interest included vitamin D, depression, and demographic characteristics. The research
question was:
Research Question 1: What is the relationship between vitamin D levels and
depression and is it moderated by demographic characteristics (gender, age, smoking
status, or marital status)?
H0: There is no relationship between vitamin D levels and depression and it is not
moderated by demographic characteristics (gender, age, smoking status, or marital
status).
HA: There is a relationship between vitamin D levels and depression and it is
moderated by demographic characteristics (gender, age, smoking status, or marital
status).
Nature of the Study
To answer the stated research question, a quantitative, ex post facto
comparative research design was used. Data were extracted from the National Health and
Nutrition Examination Survey (NHANES), which was administered in 2005-2006 (CDC,
2013). NHANES is a well-established program in the United States designed to monitor
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a variety of health and nutrition measurements and status of adults and children (CDC,
2013). The study’s sample consisted of adults who were at least 18 years old located in
the U.S. To be included in the sample, adults must have taken part of the NHANES in
2005 – 2006. Approximately 4,773 individuals, aged 18 years and older, participated in
the study (CDC, 2013b).
For the single research question, a moderated multiple regression (MMR) analysis
was incorporated. Depression was the single criterion variable, while vitamin D levels
were the predictor variable. A moderator was introduced to attempt altering the
relationship between other variables. This can help gauge whether a relationship between
the predictor variable and moderation variables occurs on the criterion variable (Keith,
2006). The moderation variables for the hypothesis are gender, age, smoking status, and
marital status. As such, MMR determined if specific demographic characteristics have an
impact on the relationship between depression and vitamin D levels. MMR allowed me
to determine if a predictor variable is correlated to the criterion variable, followed by
estimating the magnitude of any effect. MMR enabled me to determine the unknown
value of a variable from the known value of two or more variables. However, the size of
the sample was to be relatively large to determine statistical power. A relatively small
sample could lead to failure of detecting a moderating effect (Aguinis 2004).
Assumptions
A number of assumptions were critical to the meaningfulness of this study and
were implicit to the design of this study. I assumed that testing the relationship between
VDD and depression among sociodemographic subgroups was necessary to the context
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of this study, and could be discernible when using a large sample size. The health belief
model (HBM), which provided the theoretical framework for this study, was assumed to
be necessary because this model can explain behaviors.
There is an assumption that all research protocols, statistical processes and ethical
protections outlined by the NHANES were followed, and that all participants in the
NHANES survey answered fully, honestly, and to the best of their ability. Accurate
instrumentation and feedback supported the validity of the national surveillance survey.
It was assumed that the sampling methodology of collecting relevant data from NHANES
documents was meaningful in order to analyze the material and address the research
question and hypotheses.
Scope and Delimitations
The conceptual framework for this study applied the HBM deductively as a
logical process in order to focus on the attitudes and beliefs of participants. The research
question and hypothesis was verified by the HBM. NHANES datasets were examined
according to adults ≥ 18 years with VDD and depression who volunteered information
pertaining to the predictor variable and the criterion variables during a specific period
(2005-2006).
This study was delimited to adults who are at least 18 years old, located in the
United States, and who have taken part within a specified biannual (2005-2006)
NHANES dataset(s). The extent of the research study focused solely on the hypotheses
and did not surpass the theoretical foundation that the research study was established
upon. Depression and VDD were measured using an instrument designed to monitor a

7
variety of health and nutrition measurements. The study’s results were generalizable
only to adults who take part in the NHANES.
Limitations
There were multiple limitations to the design of this study. The hydrophobic
qualities of vitamin D and the tight binding that occurs to the vitamin D binding protein
can inhibit accurate measurements (Romagnoli, Pepe, Piemonte, Cipriani, & Minisola,
2013). The pseudo-quantitative nature of the method (i.e., subjective data that are
assigned numeric values without objective affirmation) served as a form of misreporting,
which can constitute as a limitation. Concerning quality control purposes, only 5% of the
interviews were recorded and reviewed (CDC, 2013). Not all interviews are reviewed,
which may indicate a misrepresentation to the general audience.
While it may appear suitable to implement the conclusion to the population, it
may not be a correct or proper assumption to all volunteers who resided in various areas
of the U.S. Persons who were U.S. nationals living abroad, institutionalized, or residing
in nursing homes, were excluded from this study and were not examined. The concern of
generalization was described as a limitation to this present study. Criteria for
participating required that volunteers who were at least 18 years old, located in the
United States, were not institutionalized, and who were mentally able to respond to a
questionnaire. These requirements reduced the ability to generalize results to the U.S.
population as a whole. Lastly, Statistical Package for the Social Sciences (SPSS) was
used to appropriately examine data; however, limitations existed due to examiners being
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required to appropriately interpret information that may have required additional
learning.
Theoretical Framework
The HBM, developed during the 1950s by psychologists Rosenstock, Hochbaum,
and Kegels, is a psychological health behavior change model that is grounded in the
sociopsychological theory of thought processes to health-related behaviors of an
individual (Harrison, Mullen, & Green, 1992). It is hypothesized that for an action to be
health-related, the individual must be dependent on three factors that occur
simultaneously: (a) a health concern must exist for an issue to be considered relevant, (b)
one must believe that they are vulnerable to a perceived health threat or condition, and (c)
a belief that abiding by suggested health recommendation could be helpful to avoiding or
lowering the possible threat at a cost (i.e., financial) that is relatively acceptable (Edberg,
2010; Janz & Becker, 1984; Rosenstock, 2005).
People often fail to take health-related action or comply with medical advice
because they do not recognize the benefits of protecting their health (Rosenstock, 2005).
Individuals who fail to take corrective action often believe they will not be impacted by
an illness. They fail to believe that personal intervention can avoid or stabilize a
condition that they are faced with (Edberg, 2010; Janz, & Becker, 1984; Rosenstock,
2005). HBM is a model that addresses behavioral change (Rosenstock, 2005).
The HBM is relevant to addressing VDD and depression because the conceptual
framework provided by the HBM is effective in understanding health behavior and
possible reasons for non-compliance (i.e., not engaging in behaviors to avoid VDD and
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depression). The HBM consists of six concepts: (a) perceived susceptibility, (b)
perceived severity, (c) perceived benefits, (d) perceived barriers, (e) cues to action, and
(f) self-efficacy that represent perceived threat and net benefits (Akompab et al., 2013).
These concepts facilitate health action and can be applied to address reasons an
individual may be non-compliant (Rosenstock, 2005).
According to Carpenter (2010), the HBM was developed so that researchers could
understand the beliefs that should be targeted to influence health behaviors. However,
the HBM was not designed to determine if subjects would adhere to a treatment program
for an existing condition. Rather, the HBM was developed so that researchers may
understand the benefits and barriers to predicting behaviors directed toward preventing
negative health outcomes (Janz & Becker, 1984). HBM was not designed to predict
treatment for existing disorders, but was rather initiated to predict the compliance of
preventative measures with those who are not suffering from an existing disabling disease
(Rosenstock, 1974).
According to Janz and Becker (1984), a cue to action is necessary to generate
health-promoting behavior. The HBM theory related to this study’s approach and
research question by examining predictors of depression in persons with VDD. This
study will enhance the general public’s understanding to predictors of depression in
persons with VDD. This study will contribute to existing research involving any
association between depression and VDD, which may help address an area that is in need
of further research.
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Significance
This study will have significance for both scholarship and practice in public
health education. Understanding if a relationship between VDD and depression is
impacted by demographics (gender, age, smoking status, and marital status) is important
for preventive strategies when allocating resources and targeting education programs.
This study can also assist in further research of distinguishing those groups at risk for
VDD and depression as an implication for positive social change, which is consistent
with and bounded by the scope of this study. Such potential contributions may advance
practice by targeting solutions toward these stakeholders.
The correlation among vitamin D status, cognition, and mood has been
documented in previous studies (McCann & Ames, 2008; Wilkins et al., 2006), where
some conclude that treating VDD improves depression symptoms (Benton, Haller, &
Fordy, 1995; Mozaffari-Khosravi, Nabizade, Yassini-Ardakani, Hadinedoushan, &
Barzegar, 2013). VDD may be indicative to underlying biological vulnerability for
depression, but further research is warranted (Milaneschi et al., 2013). According to
Nemeroff and Vale (2005), there is a strong possibility that psychiatric illnesses result in
increased vulnerability when coupled with environmental influences. In addition, some
studies have found VDD to be associated with multiple chronic debilitating diseases (e.g.,
osteoarthritis, cardiovascular disease, and type 1 diabetes; Holick, 2004; Tamai et al.,
2013).
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Definitions
Age: Age is interpreted as the amount of time during which a person has lived
(Merriam Webster, 2013a).
Depression: Depression is a serious medical condition in which a person feels
very sad, hopeless, and unimportant and often is unable to live in a normal way (Merriam
Webster, 2013a). Depression is defined as a person acknowledging of having thoughts of
hurting oneself in some way or considering oneself as being better off dead, despite the
timeframe (CDC, 2013b).
Income: Income is defined as a gain in money that derives from capital received
in a period of time (Merriam-Webster, 2013b).
Marital status: Marital status is defined as married, widowed, divorced, separated,
never married, and living with partner (CDC, 2013).
Sex: Sex is defined as the state of being male or female (Merriam Webster,
2013c).
Smoking: Smoking is defined as the act of smoking a cigarette, cigar, etc.
(Merriam Webster, 2013d).
Socioeconomic status: Socioeconomic status is defined as a composite measure
that typically incorporates economic, social, and work status (CDC, 2013).
Vitamin D: Vitamin D is defined as any or all of several fat-soluble vitamins
chemically related to steroids, essential for normal bone and tooth structure, and found
especially in fish-liver oils, egg yolk, and milk or produced by activation (as by
ultraviolet irradiation) of sterols as calciferol orcholecalciferol (Merriam-Webster,
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2013b).
Vitamin D deficiency (VDD): Vitamin D deficiency is defined as a serum 25hydroxyvitamin D concentrations ≤20 ng/mL (50 nmol/L; Forrest & Stuhldreher, 2011).
Summary
Some researchers have indicated that there is an association between depression
and vitamin D (Wilkins et al., 2006), while some researchers concluded that the data
associating vitamin D to the development of depression is circumstantial due to
inconsistencies in research findings (Bertone-Johnson, 2009; Harris & Dawson-Hughes,
1993; Kwasky, & Groh, 2012; Schneider et al., 2000). Determining whether a
relationship exists between vitamin D levels and depression, and if it is moderated by
demographic characteristics (gender, age, smoking status, or marital status) may help
public health practitioners uncover preventive strategies and allocate resources that target
education programs. Findings in this study, which focused on the general U.S.
population, may contribute to the goal of Healthy People 2020 by gradually eliminating
demographic disparities and improve mental health through prevention.
Previous researchers have studied vitamin D status, cognition, and mood
(McCann & Ames, 2008; Wilkins et al., 2006). The use of NHANES enabled provisional
diagnoses for depression and assisted with grading the severity of depressive symptoms
(CDC, 2013b). However, what remained unknown is if variables served as important
indicators for VDD and depression when coupled with gender, age, smoking status, or
marital status. What was needed is an empirical understanding of how risk for VDD and
depression function due to gender, age, smoking status, or marital status.
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I intended to examine a representative sample of the U.S. population. Public data
between 2005 and 2006 was obtained from the NHANES. The literature review
described in Chapter 2 is an overview of the relationship between VDD and depression.
A more detailed explanation of the HBM is provided in Chapter 2. Chapter 3 is the
design and methodology. Chapter 4 is the results and analyses. Finally, Chapter 5 is an
interpretation of these findings and concludes with a description of recommendations.
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Chapter 2: Literature Review
Introduction
I evaluated the association between vitamin D and depression. There is a paucity
of epidemiological research data regarding the association VDD with depression
(Milaneschi et al., 2013). A better interpretation of the association between depression
and vitamin D levels could possibly lead to greater self-efficacy. Kennel, Drake, and
Hurley (2010) argued that VDD occurs when individuals do not receive sufficient oral
intake or obtain adequate sun exposure. Demographic factors such as gender, age, and
smoking status may contribute to individuals becoming deficient (Lange, Sparrow,
Vokonas, & Litonjua, 2012; Nanri et al., 2011).
Given adequate support, individuals at risk for VDD can more easily address
behaviors related to diet, lifestyle, screening, and convenient access to treatment (CDC,
2011). Bridging potential gaps in the literature may help support public health initiatives
involving promotional efforts geared toward increasing awareness and providing
reminders of health-related action (i.e., receiving adequate amounts of vitamin D).
Achieving a greater understanding of demographic factors and their association between
depression and vitamin D levels could possibly enhance public health education
strategies involving a person’s motivation to take positive health actions against VDD
(CDC, 2011).
This review of the literature begins with an exploration of HBM, which provides
the theoretical framework for this study. The limited body of available literature that has
examined the connection between VDD and depression is synthesized in this chapter. I
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provide background information on depression and on vitamin D and its biochemical
mechanisms. The chapter concludes with an exploration of public health education
efforts that have focused on both depression awareness and mental health as well as the
promotion of vitamin D.
Literature Search Strategy
The primary objective of the literature search was to review the key concepts of
depression and vitamin D. The secondary objective was to explore scholarly reviews
pertaining to depression and vitamin D to address the stated research question of this
study. The literature search consisted of scholarly peer reviewed literature to avoid
circulating insignificant findings, baseless claims, unsuitable analyses, and bias.
Literature for this study was gathered from scholarly journal articles, books, Walden
University research databases, University of California San Diego research databases,
Centers for Disease Control and Prevention databases, United States National Library of
Medicine, National Institutes of Health, and Google Scholar dating from 1930 to May
2014, searching varying methodologies to review the progression, distribution, and risk
factors of depression and vitamin D. Peer-reviewed articles contained in this study were
reviewed to obtain influential data and information pertaining to the scope of my study.
Secondary searches for scholarly, peer-reviewed journal articles available in print-only
format were obtained from the University of California San Diego Library. The
literature search encompassed the key words depression, calcitriol, gender, age, smoking
status, marital status, NHANES, treatment, recurrence, brain function, health risks, and
education.
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Theoretical Framework
The theoretical framework for this study is the HBM. The HBM was developed
during the 1950’s by social psychologists Rosenstock, Hochbaum, and Kegeles (1974).
This model is validated to function as a guiding theoretical framework in the scope of
preventive health behavior and compliance (Rosenstock, 2005). The HBM is used to
understand health behaviors and possible predictors of depression in persons with VDD.
The central tenet of the HBM is that an individual will partake in health-related action in
order to avoid an adverse outcome (Trifiletti, Gielen, Sleet, & Hopkins, 2005). In
addition, the HBM postulates that if an individual is in favor of avoiding a negative
outcome, he or she will take a recommended health action. Conversely, the HBM
indicates that unhealthy behaviors can result if an individual perceives they are not at risk
for a potentially negative outcome (Institute of Medicine, 2001). For example, an
individual who may be at risk for depression and wishes to avoid that situation is more
likely to take preventive recommendations such as seeking treatment than an individual
who is unconcerned about their potential risk for depression.
The interaction between perceived risk and health behavior advanced by the HBM
suggests that awareness and education about health issues can positively affect change
through improvements in individual health behavior. The HBM relates to the present
study and research question by examining predictors of depression in persons with VDD.
The material collected in this study may have a significant impact on social change by
providing efficient measures (e.g., screening and counseling) for patients with VDD to
successfully respond to depression.
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Association between Depression and Vitamin D Deficiency
Vitamin D receptors (VDR) and hydroxylases (i.e., enzymes that facilitate
hydroxylation) in different areas of the brain confirm the existence of vitamin D in its
bioactive form, known as calcitriol (Eyles, Smith, Kinobe, Hewison, & McGrath, 2005;
Prüfer, Veenstra, Jirikowski, & Kumaret, 1999). VDR and hydroxylases are located
central to the limbic system, which is where emotional and behavioral regulation occur
(Walbert, Jirikowski, & Prüfer, 2001). Depressive symptoms and impaired cognition are
associated with VDR gene polymorphisms (Kuningas et al., 2009).
Beyond VDR gene polymorphisms, depressive symptoms are associated with
vitamin D status, and the neurobiological plausibility of this association is strengthened
by data that indicates VDD influences inflammation (Capuron et al., 2003; McCann &
Ames, 2008). Although inflammation may contribute to depression (Miller, Maletic, &
Raison, 2009), vitamin D’s immunomodulatory activity may partake by down-regulating
inflammatory mediators (e.g., nuclear factor κB) that are connected to depression
(Capuron et al., 2003; McCann & Ames, 2008). According to Miller et al. (2009), active
inflammatory pathways in the brain are similar to neuropathologic findings (i.e., a
junction of reduced neurotrophic aid and modified glutamate release and reuptake) that
represent depressive disorders.
Consequences of Vitamin D Deficiency
People who feel depressed (i.e., sad or anxious) each year during the same season
are often considered to have seasonal affective disorder (SAD) that is consequential to
VDD (Gloth, Alam & Hollis, 1999). Gloth et al. (1999) studied 15 participants with
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SAD in a prospective and randomized trial to measure the hypothesis that VDD is
associated with SAD. According to Gloth et al., phototherapy was administered to seven
participants and 1,000,000 international units (IU) of vitamin D were administered to
eight participants. Gloth et al. discovered that there was an association in the progress
between depression scale scores and concentrations of circulating vitamin D (p=0.05;
r2=0.26) based on all subjects who received vitamin D improved in all outcome
measures. Although no significant changes were found in depression scale measures with
those receiving phototherapy, significant changes were found with those receiving serum
vitamin D.
Variables Impacting the Relationship between Depression and Vitamin D Deficiency
Age. A cross-sectional study involving 3,262 Chinese participants who were
aged 50-70 years were measured according to depressive symptoms and concentrations
of circulating 25(OH)D (Pan et al., 2009). Symptoms of depression were determined by
a Center for Epidemiologic Studies Depression Scale (CESDS) score (Pan et al., 2009).
Radioimmunoassay’s were measured to determine circulating 25(OH)D concentrations
(Pan et al., 2009). However, causal relations remained unknown. In addition,
investigators concluded that symptoms of depression in adult Chinese had no association
correlated with 25(OH)D concentrations (Pan et al., 2009).
Sex. A population-based cohort study involving 423 men and 531 women over
the age of 64 years was performed to uncover the association between 25(OH)D and
symptoms of depression (Milaneschi et al., 2010). Assessments of depressive symptoms
using the CESDS were taken at baseline, 3-yr, and 6-yr follow-up. The CESDS consists
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of a scale that is self-reported and has 20 items, which ranges from 0 to 60 points. A
score higher than 15 is typically considered to signify clinically relevant symptoms of
depression.
Women with 25(OH)D greater than 50 nmol/L distinguished from women having
levels less than 50 nmol/L, had experienced CESDS results of 2.2 (P=0.04) and 2.1
(P=0.02) points, respectively (Milaneschi et al., 2010). The prevalence of depressed
mood was 18% for males and 42% for females. Nearly 75% of females and 50.4% of
males had serum 25(OH)D less than 50 nmol/liter (P < 0.0001), which suggests that the
weight of the prospective relationship is greater among females compared with males
(Milaneschi et al., 2010). Milaneschi et al. (2010) concluded that there is a stronger
prospective association among women than men regarding VDD as a risk factor for
development of depressed mood (i.e., depressed mood was determined by CESDS score
of > 15).
Smoking. A double blind and randomized study investigated by Jorde, Sneve,
Figenschau, Svartberg, and Waterloo (2008) examined 441 participants (159 men and
282 women) to investigate the relationship between serum 25(OH)D levels and
depression. Jorde et al. determined that smokers compared with nonsmokers were more
depressed. Participants measured their main outcome using the Beck Depression
Inventory (BDI) score; smokers scored non-significantly higher as having clinically
relevant symptoms of depression when compared to nonsmokers (Jorde et al., 2008).
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Income. Ganji, Milone, Cody, McCarty, and Wang (2010) examined the
relationship between vitamin D status and depression of the US general population at
large. Those who were VDD (25(OH)D≤75 nmol/L) had a prevalence of approximately
50% (Ganji et al., 2010). The sample population consisted of 7970 participants, women
comprised approximately 54% of this group, while 67% were African American and
Mexican American (Ganji et al., 2010). Further, approximately, 27% lived below
poverty, and approximately 4% noted that depression occurred during periods of taking
the examination (Ganji et al., 2010). Participants living below poverty levels reported a
higher prevalence of VDD compared with participants living above poverty levels (Ganji
et al., 2010).
Vitamin D Deficiency. VDD is reported in areas with sufficient resources as
often as it is reported in areas with limited resources, which places children and adults at
risk of complications (e.g., rickets osteomalacia, and osteoporosis) (Handa, Ali Kalla, &
Maalouf, 2008; Prentice, 2008; Robinson et al., 2006) regardless of place of origin
(Prentice, 2008). In areas where resources are limited, contributors to VDD are often
linked to insufficient dietary intake of vitamin D (Awumey, Mitra, Hollis, Kumar, &
Bell, 1998). However, most vitamin D originates from determinants not contained in
one’s diet, rather from non-dietary sources (e.g., inadequate sun exposure, skin
pigmentation, clothing, keeping infants indoors; Holick & Chen, 2008; Munns et al.,
2006). The biochemical characteristics of vitamin D show strong potential in minimizing
risk of depression and mitigating depressive symptoms.
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In order to realize the benefits of this correlation, it is essential to recognize the
biochemical factors that underlie depression, as well as the biochemical characteristics
involved with vitamin D. It is also important to understand the health behavior
considerations associated with vitamin D, including discernment that over 40% of
Americans are vitamin D deficient (Forrest & Stuhldreher, 2011). Thus, it is critical that
more Americans be educated about the benefits of vitamin D to mental health, and aware
about how to achieve sufficient vitamin D levels.
Depression
Depression is a condition that reaches beyond feelings of sadness or
consternation. Each year in the U.S., depression affects approximately 14.8 million
adults, or 6.7% of those 18 years and older (Kessler, Chiu, Demier, & Walters, 2010).
Globally, approximately 350 million people are subject to depression (World Health
Organization, 2013). According to Kessler et al. (2010), depression can affect
approximately one in six men and one in four women in their lifetimes. Depression can
negatively impact a person’s quality of life, such as increasing one’s risk of mortality
(Katz et al., 2010).
The American Psychiatric Association (2012b) described depression as a serious
medical illness that adversely affects ones feelings, thoughts, and actions. The onset of
depression can result into a range of symptoms (e.g., feelings of sadness, loss of
enjoyment in activities that were previously enjoyable, insomnia, and difficulty thinking).
Depression is often caused by biochemical abnormalities (i.e., an imbalance in serotonin
and norepinephrine levels may regulate mood that may lead to depression), genetics,
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personality traits, and environmental factors (vitamin deficiency, exposure to violence,
abuse, or poverty) that can affect anyone (American Psychiatric Association, 2012b).
Depression affects men and women differently, and risk of depression varies over
the course of an individual’s lifetime. Gender has a direct correlation to depression, with
females more likely to experience depression than males. Females are often twice as
likely to encounter major depressive disorder (MDD) as males (Kessler, McGonagle,
Swartz, Blazer, & Nelson, 1993; Weissman & Klerman, 1977; Weissman et al., 1993).
This appearance of gender variation in depression may be regarded as biological factors
(e.g., genetics, neurotransmitters, and hormones) and victimization (e.g., childhood
trauma, restrictive gender roles; Ryba & Hopko, 2011).
The average age of onset for depression is 32 years (National Institute of Mental
Health, 2013). However, persons 18 to 25 years are more likely to report suicidal
thoughts and episodes of MDD (Substance Abuse and Mental Health Services
Administration, 2013). Further, the highest rates for depression occur from ages 49 – 54
years (University of Maryland Medical Center, 2013).
Mental health disorders, such as major depressive disorder, are treatable through
the use of psychotherapy and anti-depressant medications (American Psychiatric
Association, 2012b). According to the National Institute of Health (2008), 13.4% of
adults in 2008 received treatment for a mental health disorder. That same year, 71% of
adults with major depression, mostly women over 50 years, were found to use mental
health services and treatment (National Institute of Health, 2008).
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Signs and Symptoms of Depression
Depression is a medical condition, which if left untreated, can interfere with
person’s daily activities and prevent them from conducting normal activities (CDC,
2011). Symptoms can include persistent sadness, anxiousness, or a feeling of emptiness,
which can adversely impact daily activities by contributing to disturbances in sleep,
reverting to physical inactivity, and increased risk for smoking (CDC, 2011). Symptoms
of depression involve the combination of these symptoms, adversely interfering with
daily activities; these symptoms may range in severity, frequency, and duration (National
Institutes of Mental Health, 2104; New York State Office of Mental Health, 2012).
Causes of Depression
According to the National Institutes of Health (2014), depression can occur based
on a variety of factors (e.g., genetic, biological, environmental, or psychological).
However, there is a paucity of research involving neurobiological basis and
pathophysiology related to depressive disorders. Correlations have been identified
between genetics and depression, as indicated with researchers investigating adoptions
and twins (Lohoff, 2010). Despite vast improvements genome-associated studies have
developed to understand depression, researchers remain challenged with properly
identifying a single genetic variation that can substantially increase the risk of depression
(Lohoff, 2010). Recognizing that genetic variants are likely to exert just a limited
influence to the total risk of depression, various genetic factors and environmental factors
are reasonably causal to the progression of depression (Lohoff, 2010).
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Health Risks Associated with Depression
Depression can exacerbate the course of common chronic diseases (e.g., cancer,
Parkinson’s disease, heart disease, and diabetes) by complicating the recovery phase and
worsening the overall physical condition (CDC, 2012a). For instance, depression can
increase development of coronary artery disease and myocardial infarctions (Rejai et al.,
2012). Further, negative lifestyles (e.g., smoking or consuming excessive alcohol) can
interfere with treatment (Kenney et al., 2009). Both physical health risks and mental
health risks are associated with depression, which can negatively impact disease
progression.
For example, Penninx et al. (1998) conducted a prospective study involving
persons aged 71 years and older, and discovered that chronically depressed persons (i.e.,
those who are depressed for at least two years) were 88% more likely to develop cancer,
compared with non-chronically depressed elderly persons. Further, when depression was
present for more than five years, an increased risk of cancer (e.g., stomach, rectum, liver,
gallbladder, pancreas, lung, skin, uterus, prostate, bladder, kidney, and lymphatic) was
present. An alternative hypothesis linking depression and cancer is due to a raised cortisol
response to the adrenocorticotropic hormone and adrenal hypertrophy (Penninx et al.,
1998). Depression that remains persistent over relatively long periods is an important
factor that may link to future cancer developments (Penninx et al., 1998).
Depression and cancer commonly co-occur. For instance, evidence from a metaanalysis study conducted by Pinquart and Duberstein (2010) correlated depression with
elevated mortality in cancer patients. Pinquart and Duberstein (2010) investigated 105
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subjects derived from 76 prospective studies, who were an average of approximately 65
years. Further, 72% of the participants were women, and approximately 50% were
married. Findings from Pinquart and Duberstein (2010) revealed that 91% of the bivariate
associations between depression and mortality reported relative risks greater than 1.0,
which indicates there is an association between depression and elevated mortality in
cancer patients
The prevalence of depression among cancer patients increases with disease
severity and symptoms, such as pain and fatigue. According to Gross et al. (2010), MDD
can increase the hazard for cancer, markedly among females with breast cancer. Gross et
al. conducted a study on a population-based sample of 3,177 cancer-free adults from the
Baltimore Epidemiologic Catchment Area Study, which included 24 years (i.e., adults
followed between 1981 and 2005) of follow-up data and 334 cancer cases. Gross et al.
(2010) concluded that a history of major depression was associated with a higher risk of
breast cancer. Mental health and physical well-being can impact biological processes and
outcomes (Pinquart & Duberstein, 2010).
Treatment
Multiple variations of antidepressants exist (e.g., selective serotonin reuptake
inhibitors (SSRIs), norepinephrine and dopamine reuptake inhibitors (NDRIs), and
serotonin and norepinephrine reuptake inhibitors (SNRIs); American Psychiatric
Association, 2012a). According to practice guidelines of the American Psychiatric
Association (2012a), a change in dose or an augmentation of therapy is recommended for
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patients with MDD who fail with responding to treatment or attain only limited response
to treatment following 1 to 2 months of therapy while in the acute phase.
Though antidepressants are the prevailing treatment for depression, two-thirds of
people who initiate treatment fail to achieve remission (Nelson, Pikalov, & Berman,
2008). An initial treatment for depression typically includes SSRIs or psychotherapy, or
both may be used in combination (Gelenberg, 2010). However, investigators have found
that approximately 70% of subjects with MDD who have previously encountered
remission failure were often treated with only one antidepressant (Nelson et al., 2008).
Considering that depression is a recurrent disease that is often inadequately treated
(National Institute of Health, 2008), clinicians are often challenged to conform to
treatment options to determine the most effective means by avoiding recurring episodes
of depression in order for remission to occur.
Risk of Recurrence
Depression is often an episodic disease; recurring episodes of depression can
affect nearly 50% of those who recover from their first episode (Kennedy & Giacobbe,
2007). The second recurrence often begins within five years from the initial episode
(Burcusa & Iacono, 2007). In addition, 80% of those who have a second episode are
likely to have more episodes (American Psychiatric Association, 2012a). Further, for
those with a history of recurring episodes, they are likely to experience five to nine
separate recurrent episodes over the course of their lifetime (Burcusa & Iacono, 2007).
The probability of recurrence escalates with each consecutive recurrent episode of
depression (Solomon et al., 2000). In a study involving long-term treatment for MDD,
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Solomon et al. (2000) found that cumulative probability was 25% for subjects who had
one recurrence at 1-year post recovery, 42% probability for recurrence at 2-year post
recovery, and 60% probability for recurrence following 5-year post recovery (Solomon et
al., 2000). In addition, collective probability increased to 41% for subjects who had two
recurrences at 1-year post recovery, 59% probability for recurrence at 2-year post
recovery, and 74% probability for recurrence at 5-year post recovery (Solomon et al.,
2000).
Vitamin D
According to the Institute of Medicine (2011), vitamin D, also known as
calciferol, is a fat-soluble vitamin that is available as a dietary supplement and produced
endogenously. Vitamin D was originally recognized as a vitamin at the beginning of the
20th century, but is now recognized as a prohormone that is made available in two forms
of fat-soluble seco-sterols known as vitamin D2 or ergocalciferol, and vitamin D3 or
cholecalciferol (Institute of Medicine, 2011). Both forms display equivalent reactions in
the body, and effectiveness to alleviate VDD (Institute of Medicine, 2011).
Two forms of vitamin D (D representing D2 or D3) include vitamin D3 that is produced in
the skin, and vitamin D2, which is made in yeast and mushrooms exposed to UVB
radiation (Holick, 2011). Vitamin D3 and vitamin D2 are equally effective in maintaining
vitamin D status in both children and adults (Holick et al., 2008). However, not all
children and adults are capable of synthesizing sufficient vitamin D levels.
When rays strike the epidermis and dermis, 7-dehydrocholesterol absorbs
ultraviolet B (UVB) rays from the sun, which convert to previtamin D3. Previtamin D3
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then converts to vitamin D3 due to temperature dependent process (e.g., time of day,
season during the year, latitude), aging, sunscreen use, and level of skin pigmentation
(Holick, 2011). Vitamin D then travels to the liver and converts to 25-hydroxyvitamin D
[25(OH)D], also known as calcidiol (Holick, 2011). The kidneys then convert 25(OH)D
to 1,25-hydroxyvitamin D, or calcitriol, which is the active form of vitamin D (Holick,
2011). The active form of vitamin D, calcitriol (1,25(OH)2-vitamin D) is then induced by
binding to its specific ligand, the vitamin D receptor (VDR) gene (i.e., a nuclear receptor
protein that recognizes calcitriol; Holick, 2011).
Endogenously, vitamin D synthesis occurs when ultraviolet sunrays penetrate the
skin and activate synthesis via hydroxylation. Two hydroxylations occur involving
activation for vitamin D when attained from diet, supplements, and sun exposure. First,
calcidiol occurs when vitamin D is converted to 25-hydroxyvitamin D [25(OH)D] in the
liver (Institute of Medicine, 2011). Then calcitriol occurs, which is hydroxylation formed
by a physiologically active 1,25-dihydroxyvitamin D [1,25(OH)2D] (Institute of
Medicine, 2011).
Many people and healthcare clinicians believe that sufficient vitamin D intake is
achievable solely through diet; this belief is inaccurate (Kennel et al., 2010). Aside from
fatty fish, vitamin D content in most foods is relatively low (Kennel et al., 2010).
Although both modes of vitamin D are located in dietary supplements or fortified in
foods, only vitamin D3 synthesizes in human skin and vitamin D2 is synthetic and used as
an additive to foods (Ross et al., 2011). Diet alone cannot be relied upon to supply
sufficient vitamin D intake.
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Vitamin D and Brain Function
Although various mechanisms for how vitamin D affect brain function have been
proposed (Alexopoulos, 2005; Fernandes de Abreu, Eyles, & Feron, 2009; McCann &
Ames, 2008), what remains controversial is how vitamin D protects against Parkinson
disease. A high vitamin D status may serve as a safeguard from developing a brain
disease such as Parkinson’s disease (Knekt et al., 2010). According to Knekt et al.
(2010), persons with Parkinson’s are often found to have low serum levels of vitamin D,
which is associated with the degeneration of dopamine neurons.
Orme, Bhangal, and Fricker (2013) explored the development of rat ventral
midbrains and discovered that the degeneration of dopamine neurons is causal to
polymorphisms that occur in the VDR. Findings from Orme et al. concluded that
polymorphisms of the VDR permit susceptibility to Parkinson’s disease (PD) and
suggested that vitamin D3 and calcitriol may have a role with PD therapies involving
neuroprotection.
Calcitriol increases the number of dopamine neurons (Knekt et al., 2013) and
enables neuroprotection by regulating neuronal concentrations of both extra and
intracellular calcium (McCann & Ames, 2008). Calcitriol is beneficial because it reduces
toxicity levels due to excess calcium in neurons (Fernandes de Abreu et al., 2009; vinh
quoc Luong & Nguyen, 2013). VDR and hydroxylases in different areas of the brain
confirm the existence of calcitriol (Eyles et al., 2005; Prüfer et al., 1999). VDR and
hydroxylases are located central to the limbic system, also known as amygdala, which is
where emotional and behavioral regulation occur (Walbert et al., 2001). Recent studies
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suggest depressive symptoms and impaired cognition are associated with VDR gene
polymorphisms (Kuningas et al., 2009).
Although calcitriol increases the number of dopamine neurons through
neuroprotection, habitual inadequate levels of vitamin D can result in a reduction of
dopaminergic neurons, which raises the possibility of further progression to PD (Knekt et
al., 2013). Evidence by Knekt et al. (2013) exhibit that vitamin D aids in neuroprotective
effects via neuronal calcium regulation, immunomodulation, and enhanced nerve
conduction (Knekt et al., 2010). Syntheses of calcium-binding proteins enables
neuroprotection by way of inhibiting oxidation (Alexopoulos, 2005; Fernandes de Abreu
et al., 2009; Kalueff, Eremin, & Tuohimaa, 2004; McCann & Ames, 2008).
As a tenable biological risk factor for neuropsychiatric disorders, vitamin D
protects brain health and provides physiologic support in preventing depression
(Alexopoulos, 2005; Fernandes de Abreu et al., 2009; McCann & Ames, 2008).
Moreover, vitamin D provides neuroprotection because of its ability to induce the
synthesis of calcium-binding proteins (Alexopoulos, 2005; Fernandes de Abreu et al.,
2009; McCann & Ames, 2008). In addition, vital neurotrophic factors are regulated by
vitamin D, which play a role in synaptic plasticity and neurotransmission (McCann &
Ames, 2008). Neuroprotection from vitamin D occurs when neuronal concentrations of
calcium extra- and intracellular are regulated. Neuroprotective effects that benefit brain
health occur via neuronal calcium regulation, immunomodulation, and enhanced nerve
conduction (Knekt et al., 2010).

31
Benefits of Vitamin D
Growing evidence suggests vitamin D is beneficial to a healthier brain, and can
diminish the onset and development of depression (Hoang et al., 2011); however, the
mechanism that connects vitamin D to mental health requires further investigation (Ganji
et al., 2010). Vitamin D has been shown to protect brain health, and may provide
physiologic support in preventing depression (Alexopoulos, 2005; Fernandes de Abreu et
al., 2009; McCann & Ames, 2008). Vitamin D regulates vital neurotrophic factors that
play a role in synaptic plasticity and neurotransmission (McCann & Ames, 2008).
For instance, vitamin D manifests a neuroprotective effect by causing neutrophin
induction to the synthesis of calcium-binding proteins, which inhibits the brain from
producing of nitric oxide. As a result, apoptosis of neural pathways that transmit
dopamine is prevented (Alexopoulos, 2005; Fernandes de Abreu et al., 2009; Kalueff et
al., 2004; McCann & Ames, 2008). Further, inflammation may contribute to depression
as well. Vitamin D immunomodulatory activity can down-regulate inflammatory
mediators (e.g., nuclear factor κB) that are connected to depression (Capuron et al., 2003;
McCann & Ames, 2008). Given the role of vitamin D in neurological processes, the
consequences of VDD are significant; both physical and mental health consequences
have been noted in the literature.
Vitamin D Deficiency
VDD is prevalent among North Americans who may not receive adequate doses
of vitamin D through either exposure to direct sunlight or through their diets. Forrest and
Stuhldreher (2011), analyzed vitamin D levels in 4495 U.S. adults and determined that of

32
the 41.6% considered as vitamin D deficient, the majority were African American
(82.1%), followed by Hispanic Americans (69.2%) (Forrest & Stuhldreher, 2011).
Further, VDD was more common among persons with no college education, overweight,
inadequate health status, and hypertension (all p < .001; Forrest & Stuhldreher, 2011). In
North America, the majority of African Americans do not obtain optimal 25(OH)D
concentrations. This deficit stems from skin pigmentation, which reduces vitamin D skin
production (Harris, 2006).
It is therefore important to recognize that VDD risk differs by individual and
differences from person to person must be considered when intervention and corrective
action is considered. According to Vieth (1999), the onset of VDD indicates corrective
action should occur in the event anatomic, physiological, or biochemical abnormalities
exist. Corrective action entails properly administering nonpharmacological doses of
vitamin D. Further, the preferred method to derive vitamin D condition is to measure a
serum concentration of 25-OH D (Holick & Chen, 2008).
Serum 25 [OH] D is a preferred method when determining vitamin D status
because it is an effective clinical index that is used to verify vitamin D levels that are
stored (Milaneschi et al., 2010). Serum 25 [OH] D is an indicator for the amount of
vitamin D retrieved through the skin and that from diet and additives (Institute of
Medicine, 2011). In humans, vitamin D that is in circulation as a reported half-life of
approximately 15 days (Jones, 2008) to 30 days (Clements et al., 1992). 25(OH)D serves
as a biomarker to sunlight exposure. However, the effect to which 25(OH)D levels
present as a biomarker is undetermined (Institute of Medicine, 2011).
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Researchers lack consensus regarding what constitutes an appropriate serum
25(OH)D concentration cutoff (Bischoff-Ferrrari, Giovannucci, Willett, Dietrich &
Dawson-Hughes, 2006; Dawson-Hughes et al., 2005; Ganji, Zhang, & Tangpricha,
2012). Individuals with serum 25-hydroxyvitamin D levels of 30.0 to 74.0 nanograms
per milliliter (ng/mL) are found to have adequate amounts of serum 25-hydroxyvitamin D
levels (Ganji et al., 2012). However, the Institute of Medicine (2011) found persons at
risk of VDD to have serum 25(OH)D concentrations of 12 ng/mL, while sufficient serum
25(OH) vitamin D levels are found above 20 ng/mL (Institute of Medicine, 2011) and
above 30 ng/mL (Holick & Chen, 2008).
Yet, just as VDD poses health risks, so too do excessively high levels of vitamin
D, or hypervitaminosis D. Serum 25-OH D levels above 50 ng/mL are a concern for
being too high of a level (Institute of Medicine, 2011). According to the National
Institute of Health (2013), doses of vitamin D exceeding 4000 units per day over several
days may cause hypercalcemia (i.e., abnormalities with contracting muscles, releasing
hormones and brain functioning). Hypervitaminosis D can cause abnormally high levels
of calcium in the blood (Kjærgaard et al., 2012). As a result, bones, soft tissues, and
kidneys can be damaged when there is an excess of serum 25-OH D (Kjærgaard et al.,
2012).
Health Risk and Treatment for Vitamin D Deficiency
In adults, VDD is linked to hypertension, cardiovascular disease, and insulin
resistance (Saintonge, Bang, & Gerber, 2009). According to Malabanan, Veronikis, and
Hollick (1998), treatment of VDD in the U.S. consists of attaining a serum 25-OH D of
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75 nmol/L, which can be accomplished by administering 50 000 IU vitamin D3 or D2
each week for up to 8 weeks (Malabanan et al., 1998). Further, by administering 50,000
IU of vitamin D2 twice a month, Holick (2007) suggested subjects can maintain a
sufficient level of serum 25-OH D of 75 nmol/L.
The Role of Public Health Education
Mental Health
Behavioral health, which encompasses depression, is one of five public health
priorities of the U.S. Department of Health and Human Services (2013). According to
Kessler et al. (2010), each year approximately 13 million American adults have a
significant and debilitating mental health issue. A goal of Healthy People 2020 (i.e., 10
year public health objectives) is to improve mental health through prevention and by
ensuring access to appropriate mental health services. Despite such stated efforts,
persons diagnosed with psychological disorders often do not obtain adequate treatment
(Kessler et al., 2005). In addition, many who do access initial treatment fail to complete
treatment (Edlund et al., 2006; Wang, 2007).
However, the prevalence of mental health and the number of people who are
successful at gaining access and completing mental health treatment remains inversely
proportional. Depression is the third most common reason for people to visit a primary
medical care clinic after hypertension and diabetes (U.S. Department of Health and
Human Services, 2013). Also, there is a gap that often leads to attrition for those
requiring care. Critical steps required to reduce unmet needs for mental health include
receiving care that is identifiable, effective, and accessible (Pence, O’Donnell, & Gaynes,
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2012). Gaps in care and intervention can have significant negative consequences for
individuals in need of treatment.
Gaps in service may result in attrition for those requiring care, because critical
steps to reducing unmet needs for mental health care are often unmet. For instance, Pence
et al. (2012) suggested the following must occur for a clinical response to positively
impact MDD: (a) the person must enter the health care system; (b) be recognized
clinically; (c) initiate treatment; (d) receive adequate treatment; and (e) respond to
treatment. According to Pence et al. (2012), the primary care practitioner (PC) setting
plays a significant role, because PC healthcare providers manage approximately two
thirds of adults with MDD who receive treatment, while the remaining one third are
managed by mental health experts. However, despite the amount of people with MDD
that PC providers treat, gaps in PC settings often remain due to failures to identify,
initiate, and provide effective treatment (Pence et al., 2012).
According to Pence et al. (2012), patients with MDD comprise 12.5% of the PC
population; further, 47% of this patient population with MDD are diagnosed, but of the
24% of those treated, 9% are adequately treated, and 6% obtain remission. However, the
PC setting is crucial for elderly adults because patients are comfortable with discussing
depression and treatment, which is closely monitored and coordinated by healthcare
providers.
Public health education can promote health by positively supporting and
influencing individuals and communities. Further, public health education raises
awareness to audiences who require access and treatment to mental health services that
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are often essential for achieving remission (Pence et al., 2012). Public health education
may be a benefit if directed toward people with mental health disorders including
depression, by incorporating multiple healthcare providers who specialize in mental
disorders. One effective public health program, which was directed toward the PC
setting and focused on adults > 59 years with major depression, is the Improving Mood–
Promoting Access to Collaborative Treatment (IMPACT).
A multisite randomized controlled trial involving 1801 elderly patients with MDD
(17%), dysthymic disorder (30%), or both (53%) was conducted to determine the
effectiveness of the IMPACT program (Unutzer et al., 2002). The mean age was
approximately 71 years; 23% were from ethnic minority groups (12% African American
and 8% Latino), and 65% were women. Nine hundred six patients representing 18
primary care sites were randomly assigned to the IMPACT program, and 895 patients
were assigned to usual care. The IMPACT intervention was comprised of an initial visit
conducted by a depression clinical specialist (DCS; e.g., nurses or psychologists) that
involved a clinical and psychosocial history, review of educational material, and a
discussion related to patient preference of treatment (psychotherapy or anti-depressant
medication; Unutzer et al., 2002).
Although final treatment choices were determined by patient and PCP, the DCS
collaborated with PCs to review treatment plan based on a recommended algorithm (i.e.,
a choice of anti-depressant medication (serotonin-reuptake inhibitor) or a 6-8 session
course on problem solving treatment in primary care (PST-PC). Partial responders who
remained depressed and were previously taking anti-depressant medication were advised
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to increase dose or include anti-depressant medication with PST-PC. For nonresponders, they were recommended to either adjust their medication or PST-PC.
Patients were followed up in person or over the phone at least every two weeks.
After 12 months of follow up from baseline, 45% of the experimental group had 50% or
more reductions in depressive symptoms when measured with approximately 20% from
the control care group (OR 3.45, 95% CI -1.19 to -.064; p < 0.01). Unutzer et al. (2002)
concluded that the IMPACT model is more advantageous and beneficial for depression
than usual care. The U.S. Preventive Services Task Force (2013) recommends not
screening for depression in PC settings unless there is sufficient staff-assisted care to
provide proper diagnosis, efficient therapy, and follow through. Staff-assisted support as
found with IMPACT can assist with identifying and treating depression (U.S. Preventive
Services Task Force, 2011).
Vitamin D
Although depression can be identified and treated, the neurobiologic basis or
cause for depression remains unknown (Nemeroff & Vale, 2005). Whether levels of
vitamin D are causal to depression, affect the outcome of depression, or has any
relationship on depression is ambiguous among scholar practitioners (Ganji et al., 2010;
Kjaergaard et al., 2012). In a study conducted by Ganji et al. (2010), data was collected
from the third NHANES to determine whether a relationship exists between serum
vitamin D and depression. The study consisted of 7970 participants aged 15-39 years.
Participants from the third NHANES were evaluated through the use of the
Diagnostic Interview Schedule. Higher prevalence of VDD was observed by Ganji et al.
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(2010) in non-Hispanic African American women, persons living below poverty, and
persons with current depression when comparing those with adequate vitamin D
conditions. Ganji et al. determined that in participants with 25(OH)D ≤ 50 nmol/L the
OR is significantly higher compared with 25(OH)D ≥ 75 nmol/L (OR = 1.85; P = 0.021).
Ganji et al. concluded that persons with VDD are more likely to experience depression
compared with those who are vitamin D sufficient. Yet, consensus of whether VDD is
causal to depression was not determined and remains inconclusive.
Kjaergaard et al. (2012) examined the comparison of depressive symptoms in
subjects, which were evaluated with the BDI, Hospital Anxiety and Depression Scale
(HADS), Seasonal Pattern Assessment (SPA) scale and Montgomery Depression Rating
(MDR) scale, and noted that in a healthy population, supplementation of high dosage
vitamin D have no effect on depressive symptoms. In a randomized controlled trial, 114
participants in the control group reported high (>70nmol/l) serum 25(OH)D levels while
243 participants in the experimental group reported low (<55 nmol/l) serum 25(OH)D
levels; Kjaergaard et al., 2012). After further investigation whether D3 supplementation
would mitigate symptoms in persons with low serum levels of 25(OH)D, Kjaergaard et
al. concluded that low levels of vitamin D are seen as an outcome, as opposed to a cause,
of depressive symptoms.
However, results from Kjaergaard et al. (2012) are not universally recognized and
accepted. Sanders et al. (2011) conducted a randomized and double-blinded trial of
women aged ≥ 70 who were community-dwellers to examine whether supplementation of
vitamin D can affect mood. Over the course of 3-5 years during autumn and winter,
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subjects randomly received placebo or 500,000 IU of vitamin D (3). Sanders et al.
concluded that when measuring outcomes of mental health there are no significant
distinctions among the placebo and vitamin D groups detected.
Although Sanders et al. (2011) concluded vitamin D is not related as an outcome
of depressive symptoms, a previous study by Lansdowne and Provost (1988) uncovered
that vitamin D levels can impact mental health. Lansdowne and Provost (1988)
examined whether vitamin D3 supplementation during winter improves mood in healthy
subjects. Over a period of five days, 44 participants assigned to a double-blind study
were randomly administered 400 IU, 800 IU, or no vitamin D3. Lansdowne and Provost
(1988) determined that vitamin D3 significantly enhanced participants’ mood, which
resulted in a positive effect on serotonin levels, food preference, sleep, and circadian
rhythms.
Some authors have found high-dose vitamin D supplementation has a distinctive
effect on depressive symptoms (Jorde et al., 2008; Kjaergaard et al., 2012; Lansdowne &
Provost, 1988). Jorde et al. (2008) obtained similar results noted by Lansdowne and
Provost (1988). Jorde et al. (2008) conducted a randomized double-blind controlled trial
to determine the relation between 25(OH)D levels and depression. Depression was
measured using the BDI scores of 441 participants consisting of 159 men and 282
women. Subjects were provided a placebo versus 20,000 or 40,000 IU vitamin D weekly
for 12 months. According to Jorde et al. (2008), participants with serum 25(OH)D levels
less than 40 nmol/l had more depressive traits, in comparison to persons with serum
25(OH)D levels ≥ 40 nmol/l. The placebo group did not show an improvement in BDI
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scores. However, the two groups administered vitamin D did show significant
improvement in depressive traits. Jorde et al. (2008) concluded that elevated dose
supplementation of vitamin D alleviates symptoms of depression suggesting that a causal
relationship is possible.
Research remains inconclusive whether VDD is an indicator for depression or
whether depression is an indicator for VDD (Kjaergaard et al., 2012). Additional
research is essential to deduce the specific role, relationship, and indication of vitamin D
in mental disorders (Kjaergaard et al., 2012). Further, persons at risk for depression
and/or VDD should be identified and receive intervention, because both conditions can
negatively impact long-term health (Kjaergaard et al., 2012). According to Kjaergaard et
al. (2012), VDD results from depression, but is not causal. Further, supplementation of
vitamin D should not be used to treat depression, but rather patients who are depressed
may be at risk of VDD.
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Summary
Various mechanisms for how vitamin D plausibly impacts brain function have
been proposed (Alexopoulos, 2005; Fernandes de Abreu et al., 2009; McCann & Ames,
2008); but the findings have been inconsistent and not sufficiently comprehensive.
Although recent epidemiological associations exist between vitamin D and depression
(May et al., 2010), evidence is inclusive about whether VDD is linked to mental health
disorders (Bertone-Johnson, 2009). There is a paucity of information whether VDD
precedes depression, or if depression is sub sequential to malnutrition and/or behavioral
modifications (Bertone-Johnson, 2009). Until further research is conducted to determine
the association of low levels of vitamin D and the occurrence of depression, BertoneJohnson (2009) argued that researchers should currently refrain from concluding that
there is a relationship between vitamin D levels and depression.
The HBM, which postulates health action by way of preventative methods by
engaging individuals to a healthier lifestyle, was the theoretical framework for this study
and was incorporated to explain and predict health-related behaviors. The use of HBM
can address why an individual may or may not adopt healthy behaviors (i.e., accept or
reject preventative health services). In addition, the use of HBM may address and
uncover behaviors involving individuals with VDD and depression.
It is well established that depression negatively impacts a person’s quality of life.
However, what is not certain is whether a relationship exists between vitamin D levels
and depression, nor is it clear if an existing relationship is moderated by demographic
characteristics (gender, age, smoking status, or marital status). The present study fills
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gaps in the current literature because the association between depression and VDD
remains unclear. Because research remains inconclusive, this present study extends
knowledge and attempts to provide social change through the use of HBM by reviewing
efficient measures (e.g., screening and counseling) for patients with VDD to successfully
identify if there is a relationship between vitamin D levels and depression, and if it is
moderated by demographic characteristics (gender, age, smoking status, or marital
status). Chapter 3 is an explanation of the methodology used to gather and interpret the
data.
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Chapter 3: Methodology
Introduction
VDD is a complex concern to the U.S. population. Researchers consider VDD a
pandemic that is largely caused by insufficient sun exposure, which is a large source of
vitamin D for human beings (Holick & Chen, 2008). However, findings on whether the
occurrence of depression is related to serum levels of vitamin D are inconsistent
(Bertone-Johnson, 2009). I examined the relationship between vitamin D levels and
depression, and how this might be moderated by an individual’s demographic
characteristics (gender, age, smoking status, or marital status).
Research Design and Rationale
I conducted a quantitative, ex-post facto comparative research design as a
framework to assess the single hypothesis. Quantitative research incorporates causal
paths and identifies collective strength of multiple variables (Frankfort-Nachmias &
Nachmias, 2008). Comparative research studies evaluate the relationship of two
variables (Crosby, DiClemente, & Salazar, 2006). Also, coefficient ranges measure
correlation strength (Frankfort-Nachmias & Nachmias, 2008). The coefficient of
correlation is considered as Pearson’s product moment correlation coefficient, or
Pearson’s r demonstrates a linear relationship by measuring the relation between two
interval or ratio level variables (Frankfort-Nachmias, & Nachmias, 2008). Three possible
results of a comparison study could have occurred (e.g., positive correlation, a negative
correlation, and no correlation).
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When results indicate that variables increase or decrease simultaneously,
suggesting a strong positive correlation exists when Pearson’s r is near +1.00, this
constitutes as a positive correlation. Further, a negative correlation indicates that
variables increase or decrease non-simultaneously when Pearson’s r is near -1.00, which
suggests there is a strong negative correlation. However, when there is no association
between the variables, then Pearson’s r will equate to 0.
Comparison studies are performed to determine whether a relationship among
variables exists. Ex-post facto indicates that there will be no manipulation to the
predictor variable. In the case of this study, participants were not designated to any
particular group considering that data was gathered and assembled by NHANES.
Considering the purpose of this research is to obtain findings from a nationwide sample
that represents individuals with VDD and depression throughout the U.S., I conducted a
non-experimental study research design, as opposed to an experimental design, to
advance knowledge in this discipline of study.
Experimental designs enable investigators to have control over variables that are
intrinsic and extrinsic, which strengthens internal validity (i.e., the amount of change
recorded that is attributable to the investigation; McKenzie, Neiger, & Thackeray, 2009).
However, experimental designs have weak external validity because investigators are
unable to replicate real-life social conditions. Non-experimental designs evaluate the
status of a criterion variable by measuring pre and post the introduction of some
treatment (Campbell & Stanley, 1963).
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Research Questions
To guide this quantitative study, one research question was used. The variables of
interest included vitamin D, depression, and demographic characteristics. The research
question is:
Research Question (RQ) 1: What is the relationship between vitamin D levels
and depression and is it moderated by demographic characteristics (gender, age, smoking
status, or marital status)?
H10: There is no relationship between vitamin D levels and depression and it is
not moderated by demographic characteristics (gender, age, smoking status, or marital
status).
H1A: There is a relationship between vitamin D levels and depression and it is
moderated by demographic characteristics (gender, age, smoking status, or marital
status).
Operational Model
A structured view of the variables for Hypothesis 1 is displayed in Figure 1. The
predictor variable is vitamin D level, while the criterion variable is depression.
Additionally, four moderators (age, gender, smoking status, and marital status) are stated
as a condition. Effect measures are presented using the characters r, R2, and R2∆.
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Vitamin D Levels

R2 ∆ = ?

Age

Depression

R2 = ?

Gender

R2 ∆ = ?

R2 ∆ = ?

Smoking
Status

R2 ∆ = ?

Marital
Status

Figure 1. Operational model.
Population, Sample, and Sampling Methodology
Population
The study’s population will focus on adults who are at least 18 years old located
in the U.S. According to the U.S. Census Bureau (2013b), there are approximately
210,316,000 individuals throughout the U.S. that fit this criterion.
Sample
The study’s sample consisted of adults who were at least 18 years old located in
the United States. To be included in the sample, adults must have taken part in NHANES
during 2005 – 2006. Approximately 4,773 individuals, aged 18 years and older,
participated in the study (CDC, 2013b). In addition, the entire data set was used in the
study.
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Sampling Methodology
Archival data during 2005 – 2006 was extracted from the NHANES data set. The
entire data set was used to answer the research question. That is, 4773 participants made
up the sample. A complex, multistage probability technique was used to select
participants for the NHANES project. The NHANES sample consisted of a
representative sample of civilian, non-institutionalized US citizens. The sample did not
include individuals living in nursing homes, members of the armed forces,
institutionalized persons, or U.S. nationals living abroad.
Power Analysis
Minimum sample size was derived from the power table presented by Aguinis
(2004). This power table offers multiple slope variations when using moderated multiple
regression. To obtain a power ≥ 0.80, an approximate sample size of 200 is
recommended. Further, Aguinis (2004) argued, in order to identify smaller regression
slope differences, the sample size should be from 320 to 400. Preferably, group sample
sizes ought to be similar. A minimum sample size of approximately 400 (i.e., 200 per
group) was required to find a difference between regression slopes. Given the available
sample consisted of over 4700 participants, the minimum sample size for the study was
met.
Procedures
After receiving approval from Walden University’s Institutional Review Board
(IRB), data files were downloaded from the NHANES website. Research organizations
(e.g., universities, health care providers, and educators) have access to NHANES’s
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information. NHANES’ data (i.e., data involving serum 25[OH]D and depression) are
available online for public use and do not require any formal permission to gain access.
Disclaimers are indicated on the NHANES website to assure data is used solely for
statistical analysis and health research purposes (CDC, 2013).
The National Center for Health Statistics (NCHS) provides downloadable publicuse data files through the CDC’s file transfer protocol (FTP). FTP supports file sharing
by sending data electronically via Internet servers. Users of FTP can obtain
questionnaires, data sets, and documentation when accessing the NHANES website.
Instructions for obtaining these data files are available by accessing Readme files, which
are files that contain information for users to obtain basic facts (e.g., directory, contact
information, and software information) about the program.
Due to the extensive nature of NHANES and the amount of processing involved
with post-data collection, data is reported to NCHS and made available biannually as
opposed to a single point in time. NCHS Disclosure Review Board (DRB) reviews
documentation, edits and approves data before releasing any information on an ad hoc
basis. Data is often published within three months of receipt of the data.
Instrumentation
The NHANES program is directed by the NCHS, which is affiliated with the
CDC (2013). NHANES is a well-established program in the U.S. designed to monitor a
variety of health and nutrition measurements and status of adults and children (CDC,
2013). The program began during the 1960s and since its existence has surveyed over
140,000 participants in a reliable and valid format that assesses health and nutritional
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status (CDC, 2013). Currently, health data are also collected through the use of
interviews, medical examinations, and sophisticated laboratory tests.
The first three National Health Examination Surveys, (NHANES I, II and III)
were performed periodically from 1960 to 1970 as a serial program, while between each
portion of the survey, intervals were implemented. Doing so permitted adequate time to
extrapolate data (CDC, 2013). From 1971 to 1975, a nutrition component was attached
to a fourth series, which was included in the two prior periodic surveys performed during
1976-1980 and 1988-1994.
In 1999, the CDC introduced a continuous survey to increase the time required to
release datasets and estimations concerning issues of public health interest every six
months (CDC, 2013). The move away from a serial survey enabled annual estimates to
contribute to small population groups and less prevalent conditions and diseases (CDC,
2013). Currently, NHANES is conducted annually. Doing so increases opportunities for
public health practitioners to adjust survey contents to meet emerging needs (CDC,
2013).
The cross-sectional survey is conducted to annually examine 5,000 participants
who make up a U.S. nationally representative sample of the non-institutionalized civilian
population (CDC, 2013). Participants are located and selected through a statistical
process using the most current U.S. Census information (CDC, 2013). Fifteen counties
across the U.S., were randomly selected using a probability sampling technique that
involved a complex, multistage design. According to WHO (2013), multi-stage sampling
involves two or more stages, where people are chosen for interviewing from a large and
diverse population.
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To provide evidence that may guide practical decisions, NHANES sampling
procedure consists of four phases to ensure statistical conclusion validity. Phase one
involves selection of primary sampling units (PSUs), such as individual counties or a
collection of adjoining counties that are comparable to a sizeable measure. The second
phase involves PSUs being detached into divisions (e.g., city blocks or their equivalent).
In the third phase, random selection occurs for each housing unit from each
neighborhood. The fourth phase of the sampling procedure pertains to individuals being
drawn within allocated screening subdomains (e.g., age-sex- ethnicity subdomains). In
this final stage, approximately 1.6 persons are selected per household, and an
introductory letter is sent to a specific household member (CDC, 2013).
All participants who consent and take part in the survey are reimbursed for time
and travel expenses. The survey comprises of two main entities: the home interview and
health examination. The interview, which takes approximately one hour, involves a
NHANES interviewer asking questions about the participant’s diet, disease history, and
health in participant’s home. The interview is also conducted to collect information
regarding demographics, socioeconomic status, and any other health related questions.
Following the interview, participants visit a local Mobile Exam Center (MEC) where lab
tests, body measurements, dental, and physiological assessments are conducted (CDC,
2013).
To expedite, simplify, and strengthen participation, transportation is granted to
and from the MEC. Confidentiality policies are established to prevent releasing
inadvertent identification of individuals. The Health Insurance Portability and
Accountability Act of 1996 (HIPAA) Privacy and Security Rules aids in granting federal
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protection to personal health information of participants; in addition, HIPAA also
protects public health authorities (e.g., NHANES interviewers and examiners) and their
role surrounding essential public health services (U.S. Department of Health & Human
Services, 2013). For the proposed study, the data collected in 2005-2006 will be used,
which provides sufficiency of instrumentation to answer the research questions for the
current study. Since this data was previously collected, I will not make any contact with
the participants.
To generate reliable and valid statistics, the NHANES program overestimates
financially challenged people, adolescents, adults ≥ 60 years, African Americans, and
Hispanics (CDC, 2009a). Additionally, both reliability and validity are verified by
pretest and pilot studies conducted prior to the implementation of survey (CDC, 2009a).
The NHANES survey was tested and retested by the CDC to ensure reliability. Further,
MEC interview data were recorded electronically using questionnaire forms to ensure
reliability and validity of data (CDC, 2013). As part of the quality control process, check
item variables were used to verify correct data was collected (CDC, 2013). Also, during
data preparation, variable frequency counts were checked, patterns of skipping questions
were verified, and responses to questions were reviewed to determine response
reasonableness (CDC, 2013).
Operationalization of Variables
Six variables were discussed: including one predictor variable (vitamin D level),
one criterion variable (depression), and four moderating variables (age, gender, smoking
status, and marital status). The predictor and criterion variables were scaled at the
interval level, while the moderating variables were scaled at the nominal level.
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Vitamin D Levels
Vitamin D levels data for NHANES 2005-2006 were first published in June, 2008
and revised November, 2010. For the proposed study, this data will be collected from
SAS transport files located on the NHANES Web site. A two-step procedure occurred
for the laboratory assay of 25[OH]D. First, an extraction of 25[OH]D from serum with
acetonitrile undergoes treatment. The treated sample is then assayed through the use of
an equilibrium radioimmunoassay (RIA) procedure based on an antibody, which is
specific to 25[OH]D. After 90 minutes, at 20-25 °C, the sample, antibody, and tracer are
incubated. Following incubation at 20-25 °C for 20-minutes with a second antibodyprecipitating complex, phase separation occurs. After incubation and prior to
centrifugation, a NSB buffer is added to assist with the reduction of non-specific binding.
For the present study, categories for Vitamin D were defined as serum 25[OH]D
concentrations ≤ 20 ng/mL, which were used for correlation analyses (CDC, 2013b).
Two categories included VDD (serum 25[OH]D concentrations ≤20 ng/mL; code 0) and
vitamin D sufficient (serum 25[OH]D concentrations >20 ng/mL; code 1).
Depression
The patient health questionnaire (PHQ) is a self-administered survey questionnaire
that establishes provisional depressive disorder diagnoses and determines depressive
symptom severity (Kroenke, Spitzer, & Williams, 2001). The PHQ was developed to
assist primary healthcare providers make criteria-based diagnoses of DSM-IV disorders
(e.g., mood, anxiety, somatoform, alcohol, and eating; CDC, 2013b). The PHQ-9 is a
questionnaire designed to specifically focus on the nine diagnostic criteria for DSM-IV
depressive disorders. Depression is diagnosed if a symptom answered on the
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questionnaire is identified as depressed mood, and also if five or more of the nine
diagnostic criteria are identified by the participant as occurring “more than half the days”
in the previous two weeks (CDC, 2013b). Further, depression is diagnosed if a
participant acknowledges “thoughts that [you] would be better off dead or of hurting
[yourself] in some way,” has occurred, regardless of the timeframe (CDC, 2013b). The
use of NHANES offers provisional diagnoses for depression and provides clinicians the
ability to grade the severity of depressive symptoms (CDC, 2013b).
For the purpose of addressing this study’s research question, the PHQ-9
questionnaire was scored from "0" (not at all) to "3" (nearly every day). Considering that
there are individual questions that can score from 0 to 3, a total score for a respondent can
range from 0 to 27. The total score is based on cutpoints that correspond with thresholds
(i.e., a cutpoint of 5 represents mild depression, a cutpoint of 10 represents moderate
depression, a cutpoint of 15 represents moderately severe depression, and a cutpoint of 20
represents severe depression). However, for this study, a single screening of a cutpoint of
10 or greater was used to determine major depression. In any other study, a cutpoint less
than 10 will indicate no depression. A cutpoint of 10 has a specificity of 88% and
sensitivity of 88% for MDD (Kroenke & Spitzer, 2002; Kroenke, et al., 2001). Two
categories for the depression variable were used, including positive diagnosis or
depressed (code 1 for PHQ9 score >10) and negative diagnosis or not depressed (code 0
for PHQ9 score ≤ to 10).
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Gender
NHANES interviewers asked all respondents whether they were male or female
(CDC, 2013b). This variable is scaled at the nominal level. The two categories included:
(a) male (code 0); and (b) female (code 1).
Age
A common and important confounding factor to health research is age. Age was
evaluated as a categorical variable. The following five classifications of codes were used
by the NHANES interviewer: (a) 20-29 (code 0); (b) 30-39 (code 1); (c) 40-49 (code 2);
(d) 50-59 (code 3); and (e) > or = to 60 years (code 4) (CDC, 2013b).
Smoking Status
Cigarette smoking was measured on all examinees who were 18 years or older.
However, history of alternative methods of inhaling tobacco (e.g., by way of pipe
smoking, passive smoking, vaporizers, and cigars), were not included in the survey.
Further, all questions pertaining to smoking were administered by interviewers via the
Computer-Assisted Personal Interviewing-CAPI system. Within this present study,
respondents were categorized as not a current smoker (do not smoke at all; code 0) or a
current smoker (smoke daily or some days; code 1).
According to the CDC (2012a), an estimated 19% (i.e., 43.8 million) of the U.S.
general adult population were considered as smokers in 2011. This study’s findings may
potentially strengthen public health through greater awareness regarding the distribution
of cigarette smoking among individuals with VDD. The use of CAPI assures validity of
the data collected due to built-in edit checks when respondents answer questions.
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Interviewers are alerted when abnormal responses are entered and instructed to verify
responses.
Marital Status
Participants 18 years and older were inquired by interviewers of their current
status (e.g., married, widowed, divorced, separated, never married, or living with a
partner). In the present study, single (e.g., unmarried, widowed, divorced, or separated;
code 0) and married (code 1) will be used.
Data Analysis Plan
For the single research question, MMR analysis was incorporated. MMR was
used when examining the association between a predictor variable and the criterion
variable, followed by estimating the magnitude of any effect. MMR is a statistical
method used for prediction and determining if there is a moderating effect (Stone &
Hollenbeck, 1989). The purpose of MMR is to detect the unknown value of a variable
from the known value of two or more variables (Stone & Hollenbeck, 1989). MMR was
used to conduct data analysis when determining if there was a relationship between
vitamin D levels and depression, and if the relationship was moderated by demographic
characteristics (gender, age, smoking status, or marital status).
Depression was the single criterion-confounding variable, while vitamin D levels
was the predictor-confounding variable. Further, a moderator was introduced to alter the
relationship between other confounding variables. This can help gauge whether a
relationship between the predictor variable and moderator variable occurs on the criterion
variable (Keith, 2006). All regression models had a criterion available, predictor
variable, and moderator(s). The moderation variables for Hypothesis 1 were gender, age,
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smoking status, and marital status. As such, MMR determined if the demographic
characteristics had an impact on the relationship between depression and vitamin D
levels. Utilization of MMR allowed me to determine if the predictor variable was
correlated to the criterion variable, followed by estimating the magnitude of any effect.
Chapter 4 contained results displayed in three discrete sections that consisted of
the demographic, detail of analyses, and summary of results sections. The demographic
section consisted of a profile of participants who were part of the initial survey by
NHANES. The section for data analysis incorporated a thorough summary of the
analysis conducted. The analysis contained applicable assumptions and concluding
inferential results. The synopsis of results encompassed a summary of the study, study
design, outcome and information detailed in Chapter 5.
This analysis of data comprised of descriptive statistics, means, standard
deviation, and frequency where appropriate. Also, histograms, z-scores, and plots were
displayed to support assumptions of normality. In addition, a regression table and
supporting figures were presented on the conditions that a relationship or affect was
identified. For this analysis, alpha was set at p = .05 on the condition that assumptions of
normality were reached. In the event there were any violations to these assumptions, the
investigator established suitable action steps.
Threats to Validity
Validity pertains to the amount and type of error that may occur. Construct
validity is a combined critique assessment of the amount, or degree, to which empirical
data and theoretical hypotheses defend the sufficiency and suitability of translations and
operations based on test scores or other measures of evaluation (Messick, 1990).
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Construct validity indicates an experiment measures the construct it sets out to measure
(Messick, 1990). Validity can change as findings develop, making validity evidence
serially incomplete (Grimm & Widaman, 2012).
According to Campbell and Stanley (1963), there are two forms of threats to
validity: external and internal. External validity involves scientific and statistical
generalization and internal validity involves results being affected by random and bias
errors (Rothman, 2002). The NHANES was designed to minimize external and internal
validity by conducting health examinations in MECs, which provide an ideal setting for
the collection of high quality data in a standardized environment (CDC, 2013). All data
files collected in MECs are merged using the common participant number (variable
name: SEQN) to ensure information for each study participant is appropriately linked
(CDC, 2013). Further, all questionnaires addressed by study participants are administered
by trained household interviewers whose performance is evaluated and tested prior to
assessing participants (CDC, 2013).
Methodological Limitation
To reduce the possibility of there being limitations with sample size, the
NHANES administered in 2005-2006 included approximately 4,773 individuals, aged 18
years and older, in the study (CDC, 2013). Having a relatively large sample size
strengthens the possibility of there being proper distribution of the population, to which
results will be generalized. Also, interview (questionnaire) data are based on selfreported data, which is subject to non-sampling error. To mitigate self-reported data,
personal health data of participants are protected by HIPAA (CDC, 2012b; CDC, 2013).
Also, to protect the confidentiality of data obtained from sample persons, masked
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variance units (MVUs; masked variables that distinguish single counties) are constructed
for the purpose of variance estimation (CDC, 2013).
Further, there is a lack of prior research studies on the relationship between
vitamin D levels and depression, and how this might be moderated by an individual’s
demographic characteristics (gender, age, smoking status, or marital status). This lack of
research constitutes as a methodological limitation. Hence, there was an important
opportunity and need to conduct this current quantitative study for further research.
Ethical Procedures
The NCHS Research Ethics Review Board (ERB) verifies that NHANES follows
ethical procedures when conducting studies. To avoid any misunderstandings,
participants were informed that the NHANES examination is not an alternative to routine
primary care examinations. Potential participants provided voluntarily consent before
taking part in any research. Twelve weeks after the NHANES exam, each participant
was provided with a written report of findings. If any abnormalities to the survey were
detected, then a letter was immediately mailed to all participants.
Federal law (i.e., HIPAA), and ethical obligations (i.e., the Public Health Service
Act regarding provision 42 United States Code 242m) assures respondents strict
confidentiality that any personal information collected by NCHS is protected (CDC,
2012b). To ensure that all personal information is collected and stored, restrictions were
imposed and guidelines were implemented (CDC, 2012b). For instance, random
inspections by the NCHS Confidentiality Officer aid with assuring confidentiality
standards were maintained (CDC, 2012b).
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Also, the NCHS Associate Director for Science (ADS) has responsibility to
review and assure adherence to restrictions pertaining to confidentiality and disclosure
remain within compliance (CDC, 2012b). For instance, the ADS reviewed public-use
audio and video components (e.g., tapes, CDs, DVDs) to ensure confidentiality and
conduct an editorial review (e.g., formatting and proper punctuation) of all products for
efficiency (CDC, 2012b). Protecting confidentiality of individual identifiable
information required maintaining restrictions on how information was collected.
To uphold such restrictions, the Public Health Service Act (Section 308 [d]) was
passed to enforce statutorily based requirements on any data collected by the NCHS and
CDC for the objective of obtaining analysis and reporting health statistical information
(CDC, 2012b). Within Section 306 of the Public Health Service Act (42 USC 242k), the
section indicates that NCHS is authorized to collect data via telephone surveys, mail
surveys, and electronic technology (e.g. e-mail; CDC, 2012b). This law was passed to
prohibit efforts of data users to determine the identity of data subjects (CDC, 2012b).
Should any such discovery occur, notification must be communicated to NCHS (CDC,
2012b). Further, any identity linking data subjects from alternative NCHS or non-NCHS
datasets is prohibited under the Public Health Service Act (CDC, 2012b). Finally, the
collection of data involving any personal favors, gifts, or payment to respondents is
prohibited under this law.
The NHANES program allows availability of downloading data in their website
(CDC, 2013). NHANES data files are stored in a statistical analysis software (SAS)
transport file format (.xpt; CDC, 2013). A SAS-accessible library is available for
software users through the use of XPORT statements that communicate to SAS to extract
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data from the transport file (CDC, 2013). The latter is accomplished by using the
XPORT engine, which is conducted in an open SAS-accessible format. Having an open
statistical software program available allows data collected by NCHS and CDC to remain
vendor neutral and omit any endorsement or requirement that can be potentially solicited
by any vendor (CDC, 2013). SAS allows data entry, report writing, statistical analysis,
and development of project management and operations research to occur in a safe and
controlled format (CDC, 2013).
Safeguarding data is of utmost importance to NCHS (CDC, 2013). To protect
NHANES participants’ confidentiality, the Confidential Information Protection and
Statistical Efficiency Act (CIPSEA) was passed. At all times, records such as names,
addresses, and social security numbers are kept secured and locked when not in use.
Finally, confidential records must remain within NCHS, unless assurance of
confidentiality is transferred to a receiving party with the same protection level of
confidentiality. According to the CDC (2013a), measures of security (e.g., access
control, user authentication, encryption, and access monitoring) are in place to protect
statistical and analytical information. The PHSA upholds strict confidentiality and was
passed into law in order to prohibit NCHS from using or sharing any personal
information for any purpose aside from what was described and agreed by participants
(CDC, 2013). Any violation of the PHSA can result in fines and imprisonment based on
provisions set forth by the CIPSEA (CDC, 2013).
The CIPSEA has a unique responsibility to protecting information, as does the
NCHS, which is responsible for outlining procedures of dissemination of NHANES data
(CDC, 2013). NCHS disseminates public-use data files (e.g., results of epidemiologic,
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demographic, and methodological research; CDC, 2009). The CDC disseminates
community health assessments and information by way of print (e.g., publications in
peer-review journals), electronic (e.g., Listserv and e-mail), audiovisual (e.g., audio and
broadcast scripts), and oral (e.g., formal speeches and oral presentations; CDC, 2009).
Summary
This quantitative study was constructed to examine the association between
vitamin D and depression status. The research methodology that was applied to achieve
this purpose is specified in this chapter. Additionally, the population and sample, data
collection procedures, and data analysis are specified in this chapter. Lastly, ethical
considerations are identified to secure confidentiality and protection of those who are
surveyed.
An analysis of the study, explanation of the results, significance, significance of
the results, limitations of the study, and recommendations for prospective research are
integrated into Chapter 4. Chapter 5 incorporates a summary of the data collected, the
data analysis process, and the findings of the study, as they pertained to the hypotheses
and research question.
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Chapter 4: Results
Introduction
The purpose of this current quantitative study was to examine the relationship
between vitamin D levels and depression, and how this relationship might be moderated
by an individual’s demographic characteristics (gender, age, smoking status, or marital
status). The examination involved a nationwide sample of those aged 18 years and older,
representing the U.S. population between 2005 and 2006. One research question was
used to guide this quantitative study. The variables of interest included vitamin D,
depression, and demographic characteristics.
This chapter begins with a summary of the applied statistical methods and the
results consisting of a detailed summary of the evaluated participants. Next, this chapter
presents a discussion of the descriptive statistics of the sample, and a review of the
independent variable in relation to the criterion variable. The description of the sample is
followed by a discussion of the data analyses, which made use of MMR analysis to
determine if a significant relationship between depression and vitamin D levels was
moderated by demographic characteristics (gender, age, smoking status, or marital
status). Data were screened for univariate outliers, and tests for assumptions of
normality, linearity, and homoscedasticity were conducted. Finally, this chapter
concludes with a summary of my findings.
Data Collection
Data were collected from selected individuals, aged 18 years and higher, to
examine the relationship between vitamin D levels and depression, and how this
relationship might be moderated by an individual’s demographic characteristics. Data
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collection took place between January 2005 and December 2006. Data documenting
vitamin D levels and depression, both with and without the covariates of gender, age,
smoking status, or marital status were collected and analyzed using MMR. Data analyses
were conducted on the entire data set using SPSS Statistics 22.0.
Population and Sample
The population of interest consisted of adults who are at least 18 years old located
in the U.S.; approximately 210 million U.S. residents that fit this criterion. Complex,
multistage probability technique was used to select participants for the NHANES project
(CDC, 2013). The sampling procedure for the NHANES consisted of four phases to
ensure statistical validity. Phase one involved selection of PSUs. The second phase
involved PSUs being detached into divisions. In the third phase, random selection was
performed for each housing unit from each neighborhood. The fourth phase of the
sampling procedure pertained to individuals being drawn within allocated screening
subdomains. The multi-stage procedure was established to ensure that the sample
consisted of a representative sample of civilian, non-institutionalized US citizens (CDC,
2013).
Overestimating reduced the likelihood of biased estimates occurring in this
current study, while increasing the reliability and validity of indicator estimates of health
status. To reduce the occurrence of discrepancies during data collection, the NHANES
program overestimated financially challenged people, adolescents, adults ≥ 60 years,
African Americans, and Hispanics (CDC, 2009a). The sample did not include
individuals living in nursing homes, members of the armed forces, institutionalized
persons, or U.S. nationals living abroad.
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Data Analysis Procedure
Inferential statistics were used to draw conclusions from the sample tested. SPSS
22.0 was used to code and tabulate scores collected from the survey and provide
summarized values where applicable including the mean, central tendency, variance, and
standard deviation. MMR analyses were used to evaluate the research question. The
research question was:
RQ 1: What is the relationship between vitamin D levels and depression and is it
moderated by demographic characteristics (gender, age, smoking status, or marital
status)?
H10: There is no relationship between vitamin D levels and depression and it is
not moderated by demographic characteristics (gender, age, smoking status, or marital
status).
H1A: There is a relationship between vitamin D levels and depression and it is
moderated by demographic characteristics (gender, age, smoking status, or marital
status).
Prior to analyzing the research question, data cleaning and data screening were
undertaken to ensure the variables of interest met appropriate statistical assumptions.
The following analysis was assessed using an analytic strategy in that the variables were
first evaluated for missing data, univariate outliers, normality, linearity, and
homoscedasticity. Subsequently, four MMR analyses were run to determine if any
significant relationships existed between the variables of interest.
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Analysis of Research Question 1
Research Question 1was evaluated using four MMR analyses to determine if a
significant relationship existed between vitamin D levels and depression, and if the
relationship was moderated by demographic characteristics (gender, age, smoking status,
and marital status). The criterion variable for the four analyses was depression as
measured by nine-items on the Patient Health Questionnaire (PHQ). Response
parameters for the nine survey items were measured on a 3-point scale where 0 = not at
all to 3 nearly every day. Composite scores were then calculated by summing case
responses across the nine PHQ items, resulting in scores with a possible range between 0
and 27. That is, higher scores indicated higher levels of depression (i.e., 5 represents
mild depression, 10 represents moderate depression, 15 represents moderately severe
depression, and 20 represents severe depression).
The predictor variable for the four analyses was vitamin D levels as measured by
the NHANES and defined in Chapter 3. The moderating variable for Analysis 1 was
gender (male, female). The moderating variable for Analysis 2 was age groups (18-29
years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older). The
moderating variable for Analysis 3 was smoking status (do not smoke at all, occasionally
smoke). Lastly, the moderating variable for Analysis 4 was marital status (single,
married).
This study’s sample consisted of 4,773 adults who were at least 18 years old
located in the United States and had taken part in NHANES during 2005 – 2006. The
NHANES sample consisted of a representative sample of civilian, non-institutionalized
US citizens, who were residing in the U.S. during the time of the study.
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Data was collected from a valid sample of 2623 participants. Specifically, the majority of
participants were female (56.5%, n = 1483) and the remaining 43.5% were male (n =
1140). Additionally, 16.7% of the participants were between 18 and 29 years old (n =
439), 17.9% were between 30 and 39 years old (n = 470), 19.1% were between 40 and 49
years old (n = 501), 16.3% were between 50 and 59 years old (n = 428), and 29.9% were
60 years and older (n = 785). Described in Table1 are frequency and percent statistics of
participants’ gender, marital status, and smoke status.
Table 1
Frequency and Percent Statistics of Participants’ Gender and Age
Demographic
Gender
Male
Female
Age groups
18 - 29 years old
30 - 39 years old
40 - 49 years old
50 - 59 years old
60 years and older
Note. Total n = 2623

Frequency

Percent

1140
1483

43.5
56.5

439
470
501
428
785

16.7
17.9
19.1
16.3
29.9

Furthermore, the majority of participants were single (53.6%, n = 1217) and the
remaining 46.4% were married (n = 1406). Lastly, there was a similar frequency of
participants that smoked (50.4%, n = 1323) as compared to those that do not smoke
(49.6%, n = 1300). Described in Table 2 are frequency and percent statistics of
participants’ gender, marital status, and smoke status.
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Table 2
Frequency and Percent Statistics of Participants’ Marital Status and Smoke Status
Demographic
Smoke Status
Do not smoke at all
Smoke
Marital Status
Single
Married
Note. Total n = 2623

Frequency

Percent

1300
1323

49.6
50.4

1406
1217

53.6
46.4

Data cleaning. Before the analyses were evaluated, the data were screened for
missing data, univariate outliers, and multivariate outliers. Missing data were
investigated using frequency counts. Upon review, it was found that 339 participants did
not provide their smoke status. These participants were removed from the analysis. The
data were screened for univariate outliers by transforming raw scores to z-scores and
comparing z-scores to a critical range between -3.29 and +3.29, p < .001 (Tabachnick &
Fidell, 2007). Z-scores that exceed this critical range are more than three standard
deviations away from the mean and represent outliers. The distributions of Vitamin D
and depression were evaluated, and 54 cases with univariate outliers were found and
removed from the analysis. There were 3016 responses received from participants and
2623 were evaluated by the MMR analysis (n = 2623). Descriptive statistics for the
criterion and predictor variables are displayed in Tables 3, 4, 5, 6, and 7.
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Table 3 displays descriptive statistics for depression and vitamin D. The average
depression score was 3.93 (SD = 3.42) while the average vitamin D score was 21.47 (SD
= 21.47). Skewness for depression is 1.60 and skewness for vitamin D was 0.43.
Table 3
Descriptive Statistics of the Criterion and Predictor Variables
Variable
Min
Depression
1.00
Vitamin D
3.00
Note. n = 2623

Max
17.00
52.00

Mean
3.93
21.47

Std. Deviation
3.42
8.87

Skewness
1.60
0.43

Kurtosis
2.27
-0.14

Table 4 displays descriptive statistics for depression and vitamin D by gender
(male, female). For males the average depression score was 3.75 (SD=3.42), while the
average vitamin D score was 21.14 (SD = 8.32). Skewness for depression in males was
1.72 and skewness for vitamin D in males was 0.41. For females, skewness for
depression was 1.52 and skewness for vitamin D was 0.43.
Table 4
Descriptive Statistics of the Criterion and Predictor Variables by Gender
Variable
Male
Depression
Vitamin D

n

Min

Max

1140
1140

1.00
3.00

17.00
52.00

Female
Depression
Vitamin D

1483
1483

1.00
3.00

17.00
52.00

Mean

Std. Deviation

Skewness

Kurtosis

3.75
21.14

3.42
8.32

1.72
0.41

2.68
0.09

4.07
21.73

3.42
9.26

1.52
0.43

2.02
-0.31

Table 5 displays descriptive statistics for depression and vitamin D by age (i.e.,
18-29 years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older).
For the age group 18-29 years old, the average depression score was 3.89 (SD = 3.38),
while the average vitamin D score was 22.08 (SD= 9.35). Skewness for depression for
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the age group 18-29 years old was 1.63 and skewness for vitamin D was 0.49. For the
age group 30-39 years old, the average depression score was 3.67 (SD = 3.14), while the
average vitamin D score was 21.94 (SD = 9.22). Skewness for depression for the age
group 30-39 years old was 1.69 and skewness for vitamin D was 0.39. For the age group
40-49 years old, the average depression score was 4.39 (SD = 3.69), while the average
vitamin D score was 20.66 (SD = 8.60). Skewness for depression for the age group 40-49
years old was 1.44 and skewness for vitamin D was 0.52. For the age group 50-59 years
old, the average depression score was 4.24 (SD = 3.77), while the average vitamin D
score was 21.40 (SD = 8.93). Skewness for depression for the age group 50-59 years old
was 1.54 and skewness for vitamin D was 0.36. For the age group 60 years and older, the
average depression score was 3.65, while the average vitamin D score was 21.42.
Skewness for depression for the age group 60 years and older was 1.62 and skewness for
vitamin D was 0.38. Descriptive statistics of the criterion and predictor variables by age
group are displayed in Table 5.
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Table 5
Descriptive Statistics of the Criterion and Predictor Variables by Age Groups
Variable
18-29 years old
Depression
Vitamin D

n

Min

Max

Mean

Std. Deviation

Skewness

Kurtosis

439
439

1.00
3.00

17.00
52.00

3.89
22.08

3.38
9.35

1.63
0.49

2.52
-0.11

30-39 years old
Depression
Vitamin D

470
470

1.00
5.00

17.00
51.00

3.67
21.94

3.14
9.22

1.69
0.39

2.80
-0.22

40-49 years old
Depression
Vitamin D

501
501

1.00
4.00

17.00
50.00

4.39
20.66

3.69
8.60

1.44
0.52

1.61
0.07

50-59 years old
Depression
Vitamin D

428
428

1.00
5.00

17.00
51.00

4.24
21.40

3.77
8.93

1.54
0.36

1.81
-0.39

60 years and older
Depression
Vitamin D

785
785

1.00
3.00

17.00
52.00

3.65
21.42

3.19
8.48

1.62
0.38

2.40
-0.14

Table 6 displays descriptive statistics for depression and vitamin D by smoking
status (do not smoke at all, smoke). For non-smokers, the average depression score was
4.26 (SD = 3.67), while the average vitamin D score was 21.87 (SD = 8.90). Skewness
for depression in non-smokers was 1.45 and skewness for vitamin D in non-smokers was
0.39. For smokers, the average depression score was 3.61 (SD = 3.13), while the average
vitamin D score was 21.09 (SD = 8.82). Skewness for depression in smokers was 1.75
and skewness for vitamin D in smokers was 0.47. Descriptive statistics of the criterion
and predictor variables by smoking status are displayed in Table 6.
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Table 6
Descriptive Statistics of the Criterion and Predictor Variables by Smoking Status
n

Min

Max

Mean

Std.
Deviation

Skewness

Kurtosis

Do not smoke at all
Depression
Vitamin D

1300
1300

1.00
3.00

17.00
52.00

4.26
21.87

3.67
8.90

1.45
0.39

1.48
-0.22

Smoke
Depression
Vitamin D

1323
1323

1.00
3.00

17.00
51.00

3.61
21.09

3.13
8.82

1.75
0.47

3.29
-0.04

Variable

Table 7 displays descriptive statistics for depression and vitamin D by marital
status (single, married). For single, the average depression score was 3.69 (SD = 3.23),
while the average vitamin D score was 22.60 (SD = 8.66). Skewness for depression in
single was 1.61 and skewness for vitamin D in single was 0.33. For married, the average
depression score was 4.22 (SD = 3.61), while the average vitamin D score was 20.18 (SD
= 8.93). Skewness for depression in married was 1.56 and skewness for vitamin D in
married was 0.59. Descriptive statistics of the criterion and predictor variables by marital
status are displayed in Table 7.
Table 7
Descriptive Statistics of the Criterion and Predictor Variables by Marital Status
Variable
Single
Depression
Vitamin D

n

Min

Max

1406
1406

1.00
5.00

17.00
52.00

Married
Depression
Vitamin D

1217
1217

1.00
3.00

17.00
52.00

Mean

Std. Deviation

Skewness

Kurtosis

3.69
22.60

3.23
8.66

1.61
0.33

2.34
-0.16

4.22
20.18

3.61
8.93

1.56
0.59

2.04
0.04
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Test of normality. Before Analyses 1-4 were conducted, basic parametric
assumptions were assessed. That is, for the criterion variable (depression) and predictor
variable (vitamin D), assumptions of normality, linearity, and homoscedasticity were
tested. Linearity and homoscedasticity were evaluated using scatterplots, and no
violations were observed. To test if the distributions were significantly skewed, the skew
coefficients were divided by the skew standard error, resulting in a z-skew coefficient.
This technique was recommended by Tabachnick and Fidell (2007). Specifically, z-skew
coefficients exceeding the critical range between -3.29 and +3.29 (p < .001) may indicate
non-normality. Based on the evaluation of the z-skew coefficients, distributions for both
the criterion and predictor variables exceeded the critical range (depression z-skew =
33.35 and vitamin D z-skew = 9.00).
Kurtosis was also evaluated using the same method, and the distribution of the
criterion variable (depression) was found to be significantly kurtotic (z-kurtosis = 23.68).
Although the distributions were significantly skewed and kurtotic, according to the
central limit theorem, sample sizes of 30 or more approximates the mean of the
population (Durrett, 2004). With this in mind, Tabachnick and Fidell (2007) posited that
when a sample size exceeds 100, statistical tests that use the general linear model, such as
regression and analysis of variance, are robust against violations of normality. The
distributions were conditionally assumed to be normally distributed. Displayed in Table
8 are skewness and kurtosis statistics of the criterion and predictor variables.

73

Table 8
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables
Variable
Depression
Vitamin D
Note. n = 2623

n
2623
2623

Skewness
1.60
0.43

Skew Std.
Error
0.05
0.05

z-skew

Kurtosis

33.35
9.00

2.27
-0.14

Kurtosis
Std. Error
0.10
0.10

z-kurtosis
23.68
-1.44

ANOVA Analyses
Two analyses of variance (ANOVA) were conducted to determine if there were
significant differences in depression and vitamin D between gender, age, smoking status,
and marital status. Specifically, analysis 1 evaluated differences in depression
(dependent variable) and analysis 2 evaluated differences in vitamin D levels (dependent
variable). The independent variables were gender (male, female), age (18-29 years old,
30-39 years old, 40-49 years old, 50-59 years old, 60 years and older), smoking status (do
not smoke at all, occasionally smoke), and marital status (single, married).
ANOVA Analysis 1
Using SPSS 22, ANOVA was conducted to determine if a significant difference
in depression existed between gender, age, smoking status, and marital status. Results
indicated that a significant difference did exist between gender (p < .001), age (p = .001),
smoking status (p < .001), and marital status (p < .001). That is, females had
significantly higher depression scores (M = 4.07, SD = 3.42) than males (M = 3.75, SD =
3.42). For age, results from a Tukey post-hoc analysis indicated that there were several
significant differences between age groups. Specifically, participants between 40 and 49
years old (M = 4.39, SD = 3.69) had significantly higher depression scores than
participants between 30 and 39 years old (M = 3.67 SD = 3.14, p = .008) and participants
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60 years and older (M = 3.65, SD = 3.19, p = .001)—see Table 15 in Appendix A for
summary details of the post-hoc analysis. Additionally, participants between 50 and 59
years old (M = 4.24, SD = 3.77) had significantly higher depression scores than
participants 60 years and older (p = .030). Furthermore, participants that did not smoke
had significantly higher depression scores (M = 4.26, SD = 3.67) as compared to those
that do not smoke (M = 3.61, SD = 3.13). Lastly, married participants had significantly
higher depression scores (M = 4.22, SD = 3.61) than single participants (M = 3.69, SD =
3.23). A model summary of the ANOVA analysis is displayed in Table 9.
Table 9
Model Summary of ANOVA Analysis of Analysis 1
Type III Sum
df
of Squares
Corrected Model
1216.092
39
Intercept
35221.613
1
Gender
141.868
1
Age
223.354
4
Smoke Status
377.096
1
Marital Status
156.137
1
Error
29495.828
2583
Total
71268.000
2623
Corrected Total
30711.921
2622
Note. Dependent variable = depression
Source

Mean Square
31.182
35221.613
141.868
55.839
377.096
156.137
11.419

F

Sig.(p)

2.731
3084.417
12.424
4.890
33.023
13.673

< .001
< .001
< .001
.001
< .001
< .001

Partial Eta
Squared
.040
.544
.005
.008
.013
.005

Observed
Power
1.000
1.000
.941
.960
1.000
.959

ANOVA Analysis 2
ANOVA was conducted to determine if a significant difference in vitamin D
levels existed between gender, age, smoking status, and marital status. Results indicated
that a significant difference did exist between gender (sig. = .004), smoking status (p =
.001), and marital status (p < .001). That is, females had significantly higher vitamin D
levels (M = 21.73, SD = 9.26) than males (M = 21.14, SD = 8.32). Furthermore,
participants that did not smoke had significantly higher vitamin D levels (M = 21.87, SD
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= 8.90) as compared to those that do not smoke (M = 21.09, SD = 8.82). Lastly, single
participants had significantly higher vitamin D levels (M = 22.60, SD = 8.66) than
married participants (M = 20.18, SD = 8.93). There were no significant differences in
vitamin D levels between age groups (p = .313). A model summary of ANOVA Analysis
of Analysis 2 is displayed in Table 10.
Table 10
Model Summary of ANOVA Analysis of Analysis 2
Source

Type III Sum
of Squares

df

Corrected Model
10972.316
39
Intercept
1029044.010
1
Gender
628.105
1
Age
359.364
4
Smoke Status
878.370
1
Marital Status
3102.214
1
Error
195087.592
2583
Total
1415555.000
2623
Corrected Total
206059.909
2622
Note. Dependent variable = vitamin D

Mean Square

F

Sig.(p)

281.341
1029044.010
628.105
89.841
878.370
3102.214
75.528

3.725
13624.755
8.316
1.190
11.630
41.074

< .001
< .001
.004
.313
.001
< .001

Partial
Eta
Squared
.053
.841
.003
.002
.004
.016

Observed
Power
1.000
1.000
.822
.377
.926
1.000

Results Analysis 1
Using SPSS 22.0, Analysis 1was evaluated using regression and moderated
multiple regression (MMR) analysis to determine if a significant relationship existed
between depression and vitamin D levels, and if that relationship was moderated by
gender. Regression analysis was used to determine if a significant relationship existed
between depression and vitamin D. Results indicated that a significant, negative
relationship did exist between participants’ depression and vitamin D, R = .075, R2 =
.006, F(1, 2621) = 14.703, sig. (p) < .001. A model summary of the regression analysis is
displayed in Table 11.
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Table 11
Model Summary of Regression Analysis
Source
Omnibus Model

R2

R
.075

.006

Unstandardized
Coefficients
Source
B
Std. Error
(Constant)
4.551
0.175
Vitamin D
-0.029
0.008
Note. Dependent variable = depression

Standard Error
3.414

Standardized
Coefficients
Beta
-0.075

F
14.703

Sig. (p)
< .001

t
26.053
-3.835

Sig. (p)
< .001
< .001

MMR was used to test if gender moderated the relationship between vitamin D
and depression. MMR Results indicated that there was a significant relationship between
depression and vitamin D levels, R = .09, R2 = .01, F(2, 2620) = 10.59, p < .001;
however, results indicated that the relationship between depression and vitamin D was
not significantly moderated by gender, ∆R2 = .001, ∆F(1, 2619) = 2.60, ∆sig. (p) = .11
(two-tailed). A model summary of the MMR for Analysis 1 is displayed in Table 12.
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Table 12
Model Summary Generated from Moderated Multiple Regression Analysis 1
Model
1
2

R
.09
.10

R2
.01
.01

∆R2
.01
< .01

Unstandardized
Variable
Model 1
(Constant)
Vitamin D
Gender

B

S.E.

4.03
-0.03
0.34

0.27
0.01
0.13

Model 2
(Constant)
3.17
0.60
Vitamin D
0.01
0.03
Gender
0.87
0.36
Interaction 1
-0.03
0.02
Note. Dependent variable = depression
Interaction 1 = vitamin D * gender

∆F

df1
10.59
2.60

2
1

df2
2620
2619

∆F Sig. (p)
< .001
.11

Sig. (p)

Partial
Correlation

Standardized
Beta

t

-0.08
0.05

14.97
-3.92
2.54

< .001
< .001
0.01

-0.08
0.05

0.03
0.13
-0.14

5.32
0.42
2.45
-1.61

< .001
0.68
0.01
0.11

0.01
0.05
-0.03

Results Analysis 2
Analysis 2 was evaluated using MMR analysis to determine if the significant
relationship between depression and vitamin D levels was moderated by age groups (1829 years old, 30-39 years old, 40-49 years old, 50-59 years old, 60 years and older). As
found in Analysis 1, there was a significant relationship between depression and vitamin
D levels, R = .08, R2 = .01, F(2, 2620) = 7.58, p < .01; however, results indicated that the
relationship between depression and vitamin D was not significantly moderated by age
groups, ∆R2 < .001, ∆F(1, 2619) = 0.54, ∆sig.(p) = .46 (two-tailed). A model summary
of the MMR for Analysis 2 is displayed in Table 13.
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Table 13
Model Summary Generated from Moderated Multiple Regression Analysis 2
Model
1
2

R2

R
.08
.08

.01
.01

Unstandardized
Covariate
Model 1
(Constant)
Vitamin D
Age groups

B
4.65
-0.03
-0.03

S.E.
0.23
0.01
0.05

Model 2
(Constant)
4.40
0.42
Vitamin D
-0.02
0.02
Age groups
0.05
0.12
Interaction 2
< 0.01
0.01
Note. Dependent variable = depression
Interaction 2 = vitamin D * age groups

∆R2
.01
< .001

∆F

df1
7.58
0.54

2
1

df2
2620
2619

∆F Sig. (p)
< .01
.46

Standardized
Beta

t

Sig. (p)

Partial
Correlation

-0.08
-0.01

20.10
-3.85
-0.68

< .001
< .001
0.50

-0.08
-0.01

-0.05
0.02
-0.05

10.47
-0.97
0.42
-0.73

< .001
0.33
0.67
0.46

-0.02
0.01
-0.01

Results Analysis 3
Analysis 3 was evaluated using MMR analysis to determine if the significant
relationship between depression and vitamin D levels was moderated by smoke status (do
not smoke at all, occasionally smoke). As found in Analyses 1 and 2, there was a
significant relationship between depression and vitamin D levels, R = .12, R2 = .02, F(2,
2620) = 20.59, p < .001. However, results indicated that the relationship between
depression and vitamin D was not significantly moderated by smoke status, ∆R2 < .001,
∆F(1, 2619) = 1.04, ∆sig.(p) = .31 (2-tailed). A model summary of the MMR for
Analysis 3 is displayed in Table 14.
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Table 14
Model Summary Generated from Moderated Multiple Regression Analysis 3
Model
1
2

R2

R
.12
.13

.02
.02

∆R2
.02
< .001

Unstandardized
Covariate
Model 1
(Constant)
Vitamin D
Smoke Status

B
5.61
-0.03
-0.68

S.E.
0.27
0.01
0.13

Model 2
(Constant)
6.11
0.56
Vitamin D
-0.05
0.02
Smoke Status
-1.01
0.35
Interaction 3
0.02
0.02
Note. Dependent variable = depression
Interaction 3 = vitamin D * smoke status

∆F
20.59
1.04

df1
2
1

df2
2620
2619

∆F Sig (p).
< .001
.31

Standardized
Beta

t

Sig. (p)

Partial
Correlation

-0.08
-0.10

20.77
-4.08
-5.13

< .001
< .001
< .001

-.08
-.10

-0.14
-0.15
0.08

10.99
-2.25
-2.90
1.02

< .001
.02
< .01
.31

-.04
-.06
.02

Results Analysis 4
Analysis 4 was evaluated using MMR analysis to determine if the significant
relationship between depression and vitamin D levels was moderated by marital status
(single, married). As found in Analyses 1-3, there was a significant relationship between
depression and vitamin D levels, R = .10, R2 = .01, F(2, 2620) = 13.48, p < .001.
However, results indicated that the relationship between depression and vitamin D was
not significantly moderated by marital status, ∆R2 < .001, ∆F(1, 2619) = 1.27, ∆sig.(p) =
.26 (two-tailed). The null hypothesis was partially retained. That is, there was a
significant relationship between vitamin D levels and depression, however the
relationship was not moderated by demographic characteristics (gender, age, smoking
status, or marital status). A model summary of the MMR for Analysis 4 is displayed in
Table 15.
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Table 15
Model Summary Generated from Moderated Multiple Regression Analysis 4
Model
1
2

R
.10
.10

R2
.01
.01

∆R2
.01
< .001

Unstandardized
Covariate

B

Model 1
(Constant)
Vitamin D
Marital Status

3.79
-0.03
0.47

S.E.
0.28
0.01
0.14

Model 2
(Constant)
4.34
0.56
Vitamin D
-0.05
0.02
Marital Status
0.11
0.35
Interaction 4
0.02
0.02
Note. Dependent variable = depression
Interaction 4 = vitamin D * marital status

∆F

df1
13.48
1.27

2
1

df2
2620
2619

∆F Sig.(p)
< .001
.26

Sig. (p)

Partial
Correlation

Standardized
Beta

t

-0.07
0.07

13.52
-3.33
3.49

< .001
< .001
< .001

-.07
.07

-0.13
0.02
0.08

7.71
-2.14
0.30
1.13

< .001
.03
.76
.26

-.04
.01
.02

A final model was generated to observe the association between vitamin D and
depression after controlling for age, marital status, gender, and smoke status. Sequential
regression was used to test the final model where block 1 contained the four covariates,
and block 2 added vitamin D. Sequential regression is used to examine r-squared change
to determine if an association exists between vitamin D and depression after controlling
for the effects of the covariate. Based on findings, a significant relationship was found
between vitamin D and depression after controlling for the effects of age, marital status,
gender, and smoke status; ∆R2 = .01, ∆F(1, 2619) = 14.34, ∆Sig. (p). < .001 (two-tailed)
A model summary of the final model is displayed in Table 16.
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Table 16
Final Model Summary Generated from Sequential Multiple Regression Analysis
Model
1
2

R

R2

∆R2

0.14
0.16

0.02
0.03

0.02
0.01

Unstandardized
Covariate

B

S.E.

Model 1
(Constant)
Gender
Smoke Status
Marital Status
Age

3.79
0.64
-0.80
0.72
-0.01

0.44
0.16
0.15
0.15
< .01

Model 2
(Constant)
4.72
0.49
Gender
0.68
0.16
Smoke Status
-0.84
0.15
Marital Status
0.63
0.15
Age
-0.01
< .01
Vitamin D
-0.04
0.01
Note: Dependent Variable = Depression

∆F

df1

12.96
14.34

df2
4
1

∆F Sig.(p)

2620
2619

< .001
< .001

Sig. (p)

Partial
Correlation

Standardized
Beta

t

0.08
-0.11
0.09
-0.05

8.65
4.10
-5.37
4.77
-2.34

< .001
< .001
< .001
< .001
.02

.08
-.10
.09
-.05

0.09
-0.11
0.08
-0.05
-0.09

9.73
4.37
-5.66
4.12
-2.46
-4.40

< .001
< .001
< .001
< .001
.01
< .001

.08
-.11
.08
-.05
-.09

Summary
In summary, vitamin D is essential to optimizing health and preventing disease
(Bertone-Johnson, 2009). Therefore, there is a need to determine whether VDD is
physiologically correlated to the occurrence of depression (Bertone-Johnson, 2009). My
intent for researching this current study was to explore whether there is a relationship
between vitamin D levels and depression, and how this might be moderated by an
individual’s demographic characteristics such as gender, age, smoking status, or marital
status.
The ex-post facto exploratory MMR analysis of this current study indicated that
there was a significant relationship between vitamin D levels and depression; however
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the relationship was not moderated by demographic characteristics (gender, age, smoking
status, or marital status). Table 17 provides a summary of the results for all analyses.
There were no statistically significant relationships between any of the predictor
variables, concluding that the predictor variables and the interaction effects do not have a
significant effect on the outcome variable. In Chapter 5, I provide a detailed discussion
of these results. Additionally, I present study limitations, recommendations for future
studies, and implications for social change. The final model, though did find a significant
relationship between vitamin D and depression after controlling for the four covariates.
Table 17
Summary of Results for Analyses 1-4
Hypothesis

Criterion Variable

Predictor Variable

Moderator

1

Depression

Vitamin D Levels

Gender

2

Depression

Vitamin D Levels

Age Groups

3

Depression

Vitamin D Levels

Smoke Status

4

Depression

Vitamin D Levels

Marital Status

Final
Model

Depression

Vitamin D Levels

Gender, Age,
Smoke, and
Marital Status

Test
Moderated Multiple
Regression
Moderated Multiple
Regression
Moderated Multiple
Regression
Moderated Multiple
Regression
Sequential
Regression

∆
Sig.(p)
.11
.46
.31
.26
< .001
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Chapter 5: Discussion
Introduction
The purpose of this current quantitative study was to examine the relationship
between vitamin D levels and depression, and how this relationship might be moderated
by an individual’s demographic characteristics (gender, age, smoking status, or marital
status). Results of the analyses indicate that vitamin D levels are associated with
depression. Yet, following the adjustment of demographic characteristics, the relationship
between vitamin D levels and depression was not moderated by demographic
characteristics (gender, age, smoking status, or marital status). The findings of this study
contribute to the existing body of literature that has explored the implications of VDD in
relation to mental health by confirming the correlation with depression and indicating that
this finding did not vary by the selected moderating variables of gender, age, smoking
status, or marital status.
Many studies have researched the relationship of vitamin D status in persons with
depression. However, to date, the results of these studies remain controversial (BertoneJohnson, 2009; Harris & Dawson-Hughes, 1993; Kwasky, & Groh, 2012; Schneider,
Weber, Frensch, Stein, & Fritze, 2000). Prior to the current study, no published research
has explored the association between vitamin D levels and depression by determining if
this relationship is moderated by demographic characteristics (gender, age, smoking
status, or marital status). My purpose was to highlight original research by offering a
new perspective to the field of public health.
This current study provides evidence-based research to support the
implementation and achievement of the 10-year national objectives set forth by
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HealthyPeople 2020, which is a strategic plan for improving the health of all Americans.
As the federal government continues to enhance health reform legislation, this study can
provide direction to persons with VDD and depression and their providers, including new
screening opportunities and education services that empower individuals to make
informed health decisions.
Bertone-Johnson (2009) conducted a meta-analysis that investigated primary
research literature that suggested and refuted whether serum vitamin D and depression
are associated. Bertone-Johnson completed the study without conclusion and
recommended further research. Further, Bertone-Johnson cautioned that it was premature
to relate the occurrence of depression to vitamin D status and that many cross-sectional
studies have presented unadjusted results not taking into consideration confounders (e.g.,
age, time spent outdoors, latitude, physical activity, body mass index, smoking and
alcohol use; Brot, Jorgensen, & Sorensen, 1999; Gerdhem, Ringsberg, Obrant, &
Akesson, 2005; Holick, 2008; Santori et al., 2008). These same confounders are also
associated with depression and vitamin D status (Jané-Llopis & Matytsina, 2006; Pasco
et al., 2008; Roberts, Kaplan, Shema, & Strawbridge, 1997). Researchers have not been
able to determine whether these associations occur from confounders (Michelson et al.,
1996; Schneider et al., 2000; Wilkins, Sheline, Roe, Birge, & Morris, 2006).
Each year nearly 13 million adults in the U.S. experience depression, a serious
and disabling mental health issue causing social distress and impaired quality of life
(Kessler et al., 2010). According to the CDC (2011b), from 2001 to 2006, approximately
33% of the U.S. population was at risk of having low levels of vitamin D (serum 25OHD
30–49 nmol/L), while approximately 8% were at risk of VDD (serum 25OHD less than

85

30 nmol/L). Further, the prevalence was higher in persons who were adult, female, or
minority (CDC, 2011b). This study was conducted to determine if statistical and
theoretical support should be applied for the association of vitamin D levels and
depression. Although there is evidence that Vitamin D is vital to enhancing health and
reducing the risk of disease (Bertone-Johnson, 2009), there is a paucity of research
whether VDD is physiologically related to the occurrence of depression (BertoneJohnson, 2009). This study was conducted to explore whether there is a relationship
between vitamin D levels and depression, and how this might be moderated by an
individual’s demographic characteristics such as gender, age, smoking status, or marital
status.
This present study was developed according to a quantitative, ex-post facto
comparative research design. Medical, mental, and laboratory results were derived from
2005-2006 NHANES data (CDC, 2013). The study’s sample consisted of adults at least
18 years old, resided in the U.S., and had taken part of the NHANES in 2005 – 2006.
The single research question for this present study integrated a MMR analysis to
determine the effect of a predictor variable (VDD) on a criterion variable (depression), is
dependent on the moderators (gender, age, smoking status, and marital status).
Moderators were introduced to explore if the demographic characteristics impact the
relationship between depression and vitamin D levels, which helped determine that the
predictor variable was correlated to the criterion variable. Further, I would have been
able to determine the magnitude of any effect if the moderating variables had exerted
influence on the correlation.
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Summary of Findings
In this study, a sample of 2623 adults located within the United States were
evaluated. Data was entered into SPSS 22.0 and were then tested using MMR analysis to
evaluate the research question. The research question was, What is the relationship
between vitamin D levels and depression and is it moderated by demographic
characteristics (gender, age, smoking status, or marital status)?
Results of Research Hypothesis 1
H10: There is no relationship between vitamin D levels and depression, and it is
not moderated by demographic characteristics (gender, age, smoking status, or marital
status).
H1A: There is a relationship between vitamin D levels and depression, and it is
moderated by demographic characteristics (gender, age, smoking status, or marital
status).
Using SPSS 22.0, Hypothesis 1 was evaluated using four MMR analyses to
determine if a significant relationship existed between vitamin D levels and depression,
and if the relationship was moderated by demographic characteristics (gender, age,
smoking status, and marital status). Results from Analyses 1-4 indicated that there was a
significant relationship between depression and vitamin D levels (p < .001). However,
the relationship between depression and vitamin D was not significantly moderated by
gender (∆p = .11), age (∆p = .46), smoke status (∆p = .31), or marital status (∆p = .26).
The null hypothesis for the Research Question was rejected in part and retained in part.
Though a correlation was found between vitamin D and depression, the moderating
variables did not exert influence.
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This data represents new findings that contribute to the literature on addressing
VDD and depression, which may further lead investigators to lower the rates of both
adverse health conditions. Further, inconsistencies in the prior research stem from a
failure to identify any possible significant differences in this relationship by gender, age,
smoking status, or marital status. This current study has the potential to assist public
health practitioners in promoting prevention strategies and developing appropriate
intervention strategies designed to address at risk individuals with VDD and depression.
The findings of this study are significant for determining the relationship between
vitamin D levels and depression, which can assist with distinguishing groups at risk of
VDD and depression and measures to target solutions directed toward these particular
individuals. The model in this study supports prior research that had also affirmed a
correlation between vitamin D levels and depression (Jorde et al., 2008; Kjaergaard et al.,
2012; Lansdowne & Provost, 1988).
Strengths of the Study
The current study obtained data from a nationally representative multistage,
random sample of non-institutionalized individuals who reported being 18 years or older
at the time of data collection. The survey set files were in SAS transport file format,
which were used to account for complex probability and proper analysis of the data that
specifically incorporated sample design complications such as weighting and clustering.
Data for the study was obtained from NHANES 2005-2006. Analytic guidelines were
followed to monitor weighting, variance estimation, and sample design to ensure
recommended methodologies were compliant when obtaining survey estimates,
computing sample variances, and recommending sample sizes for analysis. Further,
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through the protection of public health laws, all data collected is private and strictly
confidential.
Limitations of the Study
As with most research, the results of this study are constrained by a number of
limitations that must be acknowledged. Though these limitations must be considered in
relation to the study findings, the conclusions of the study make a valuable contribution
to the existing body of literature on this subject. First, it must be noted that the causal
relationship between VDD or vitamin D levels cannot be established based on the nature
of the MMR analysis. Kjaergaard et al. (2012) indicated that the association between
VDD and depression could be bidirectional, which suggests more research is needed to
determine causality.
Generalizability
This study targeted only non-institutionalized adults over the age of 18 years; this
may have impacted the generalizability of my results because of partial representation.
The sample consisted of non-institutionalized civilian adults who were at least 18 years
old, resided in the U.S and had taken part of the NHANES in 2005 – 2006. In addition, I
cannot determine whether there are limitations to NHANES ability to estimate population
trends that are pertinent. Therefore, these findings may not be generalizable to other
populations.
Validity
This current study’s assessment was conducted using the PHQ-9 questionnaire, a
screening and diagnostic instrument, which measures depression. According to Kroenke
et al. (2001), the PHQ enables provisional depressive disorder diagnoses and establishes
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depressive symptom severity. Data from the PHQ-9 were collected to determine a
respondents’ major depression score according to the respondents’ self-reported
retrospective perception. Although the CDC (2013) considers the PHQ a reliable and
valid tool for diagnosing depression, concerns with validity should be considered because
perceptions of oneself may be different than reality, as seen by the interviewer or others.
Although PHQ-9 is a useful screening instrument and is efficient for assessing a general
population (Inoue et al., 2012), research validating the specificity of the PHQ-9
questionnaire remains unavailable (Kroenke et al., 2001).
Reliability
NHANES is a reliable reference that is dependable, accurate, and honest (CDC,
2013). Federal agencies (e.g., the National Institutes of Health, the Food and Drug
Administration, and CDC) formulate and implement national health policy agendas and
resource allocation activities. Such research centers depend on NHANES to develop and
disseminate data necessary for planning and executing public health activities (Novick,
Morrow, & Mays, 2008). As a reliable source of national-level prevalence and tends of
selected diseases and risk factors, NHANES facilities community health planning and
monitoring prevention effectiveness. To generate reliable statistics, over-sampling
occurred to adjust the class distribution of the data set. As a means to control reliability,
a U.S. national representation of those 18 years and older, (i.e., persons 60 and older,
African American, and Hispanics) were over-sampled to ensure that there were enough
respondents reporting for this group.
However, the use of secondary data increases the probability of measurement
error and data variance. Error can occur due to constructs and content validity of the data
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collected. Further, standard concept error could have presented errors to invalidate
secondary data. For instance, the PHQ-9 questionnaire has limited control over reliability,
because healthcare clinicians were not onsite to assess clinical findings for depression.
Further, the PHQ-9 questionnaire has limited control over reliability because the
instrument is not applicable for diagnosing current depressive episodes a participant may
be experiencing while taking the questionnaire (Kroenke et al., 2001). Further, deception
can occur to avoid embarrassment in answering questions truthfully when answering the
PHQ-9 questionnaire. Participants may have been improperly classified as not having
depression, which may impact this present study’s reliability.
Also, my actions and attitude when collecting the data could have played a role in
measurement error (i.e., deviating from the true value’s outcome when measuring
results). Finally, lag time may have played a role with increasing measurement error and
data variance due to the time that primary data was collected is different that the time the
data was published. For instance, in this study participants were examined for depression
and vitamin D levels in 2005 and 2006; however, results were not published until 2008
and updated in 2010, respectively.
Further, to produce reliable statistics, the CDC tested and retested the NHANES
data and the information collected during MEC interviews were electronically recorded.
Also, quality control processes (e.g., checking for variable frequency counts and patterns
of skipping questions), were implemented to verify collection of correct data and ensure
the survey produces stable and consistent results (CDC, 2013).
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Recommendations
Recommendations for Future Research
The results of this current study provide a basis for multiple recommendations.
Some recommendations for further research are grounded in the limitations of the current
study, involving generalization, validity, and reliability. To test this current study’s
hypothesis, archival data during 2005 – 2006 was chosen from the NHANES data set.
The entire data set was used to reflect the entire population and to answer the research
question. To reduce the generalizability to the U.S. population as a whole, volunteers
who participated in the NHANES were required to be at least 18 years, residing in the
United States, were not institutionalized, and were mentally capable of responding to a
questionnaire. However, persons living in long-term care facilities, members of the
federal military forces of the United States, those who are institutionalized, and U.S.
nationals living in a foreign country, were not included in this current study. A future
study may consider including these populations as part of the larger group, or may
examine these populations individually to gain insights into how they may be similar to
or different from the participant who were eligible for inclusion under the NHANES
parameters.
Additional recommendations for further research emerge from an examination of
the results of this study in relation to the literature reviewed in Chapter Two. More
research is needed to determine what role vitamin D supplementation may involve with
preventing and treating depression (Penckofer, Kouba, Byrn, & Ferrans, 2010).
Currently, public health initiatives are invested into raising awareness about the
importance of physical exercise, consuming foods with adequate vitamin D or
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supplementing a sufficient amount of vitamin D, to reduce the prevalence of VDD in the
U.S. If by improving vitamin D levels could enhance mental health, then taking part in
physical activity in the sun and consuming nutrients rich in vitamin D to improve VDD
could be measures that are simple and cost-effective to potentially reduce risks for
depression (Penckofer et al., 2010). Additional research is necessary to explore the
potential of supplementation in addressing this issue.
The inclusion of ethnicity as a moderating variable was beyond the scope of this
study, yet ethnicity may influence VDD on depression in adults. This current study had
ample representation of Non-Hispanic White, Non-Hispanic Black, and Hispanic
participants. However, the non-Hispanic Asian American population lacked sufficient
representation of participants in the current study. The 2005-2006 NHANES could have
oversampled non-Hispanic Asian Americans to disseminate whether there is an influence
of VDD on depression and is it moderated by demographic characteristics (gender, age,
smoking status, or marital status) on this population subgroup. Further, data analysis
involving non-Hispanic Asian Americans may add to the knowledge of ethnic
differences.
Recommendations for Practice
Most people in the United States do not recognize the severity of vitamin D
status, largely because many who have VDD feel asymptomatic (Holick, 2008). Yet,
scholar practitioners are aware that VDD can raise the risk for depression, type 1
diabetes, type 2 diabetes, cardiovascular disease, stroke, auto-immune diseases (e.g.,
multiple sclerosis and rheumatoid arthritis; Thacher & Clarke, 2011). People often
believe that they will know when the onset of VDD occurs. Signs and symptoms of
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vitamin D deficiency frequently include pain in bones, joints, and muscles, which can
lead to healthcare clinicians misdiagnosing as fibromyalgia, chronic fatigue syndrome, or
depression (Holick, 2008). The connection between vitamin D status and symptoms
revealed are often not identified by general routine examination (Thacher & Clarke,
2011).
However, prompt medical treatment and assertive vitamin D replacement are
advised at the onset of VDD (Thacher & Clarke, 2011). Often medical practioners only
provide a person who is vitamin D deficient with the required daily amount (i.e., 1000
IU/day) of vitamin D3 (Holick, 2008). This approach does not increase serum levels of
25(OH)D sufficiently (Kjærgaard et a., 2012). Although no international standard has
been established for vitamin D sufficiency, clinicians should consider rectifying VDD by
understanding that the total dose of vitamin D is more predictive of vitamin D sufficiency
rather than the frequency of dosing (Ish-Shalom et al., 2008).
Pepper, Judd, Nanes, and Tangpricha (2009) performed a retrospective analysis to
examine a suitable regimen that can be introduced to correct vitamin D insufficiency in
healthy adults. Approximately 300 healthy adults were prescribed varying levels of
vitamin D2 to determine the most effective amount to achieve vitamin D sufficiency. The
investigators concluded that at least 600,000 IU of vitamin D2 appeared to be the most
effective in achieving vitamin D sufficiency in nearly 65% of cases, avoiding vitamin D
toxicity. Pepper et al. (2009), also indicate that guidelines for treatment of vitamin D
insufficiency be developed for clinical practice to standardize the management of vitamin
D insufficiency in healthy adults.
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Implications for Positive Social Change
This current study is a response to significant impacts that depression is having on
the United States, which leads to economic strain, adversity, and dissatisfaction. In 2012,
United States health care spending exceeded $2.8 trillion, or $8,915 per person (Martin,
Hartman, Whittle, & Catlin, 2014). However, more than $25 billion was annually
attributed to medical costs directed toward depression (Wade & Häring, 2010). People
with depression and those who are providing care to those with depression can be
emotionally impacted, which can lead to immense suffering and interfere with QOL.
These results reflect spending costs toward depression. However, the spending
amount attributed to depression could be higher than $2.8 trillion; many people who have
a depressive disorder do not pursue treatment (National Institute of Mental Health, 2013).
Further, the results do not reflect psychological and emotional costs that can be attributed
to families, organizations, and societies. There is a need for positive social change at all
impacted levels (individual, family, organizational, and societal/policy).
The material collected in this study contribute to improving human and social
conditions by recommending efficient measures (e.g., screening and counseling) for
patients with VDD to successfully respond to depression. This study focused on
exploring whether there is a relationship between vitamin D levels and depression, and
how this might be moderated by an individual’s demographic characteristics such as
gender, age, smoking status, or marital status. Understanding the connection between
VDD and depression provides a basis on which to foster positive social change at the
individual level, family, organizational, and societal level.
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The results of the current study support positive social change aimed at
broadening the understanding of a relationship between vitamin D levels and depression.
This increased knowledge can positively enhance the general public’s understanding of
predictors of depression in persons with VDD. In addition, the results of this study can
contribute to preventive strategies related to both depression and VDD when allocating
resources and targeting education programs. This study can also provide a basis for
additional research focused on distinguishing groups at risk for VDD and depression,
noting that the presence of one may be correlated with the presence of the second
condition.
The connection between vitamin D levels and depression status suggests that
there is a need to recognize VDD as part of screening for development or triggering of
depression risk factors (persistent feeling of sadness and loss of interest; emotional and
physical distress). The current study shows that VDD and depression are related, thereby
extending the existing literature that improvements in QOL, physical health and mental
health are correlated to the relationship between VDD and depression. Screening
individuals with low levels of vitamin D may be a cost effective measure for determining
potential depression.
Conclusion
The personal and public health consequences of depression and VDD are
significant and evident. Depression is a significant and debilitating health illness that can
impair an individual’s quality of life and cause regular activities to become challenging.
Further, some people may be challenged with depression while concomitantly managing
an additional chronic disease, which can impact the individual and their surroundings
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(e.g., emotional burdens on family members and financial impact on society). Failure to
treat VDD or depression accordingly and effectively may cause further complications
that may result in diminished quality of life to the individual and higher healthcare costs.
Proper identification, analysis, and therapy may aid with early identification of at-risk
patients. Also, efficient tools and evidence-based protocols that provide an aligned
intervention that is patient centric can be valued as a holistic healthcare solution. By
proactively adopting practices and focusing on solutions that target the needs of persons
with depression and low vitamin D levels, public health practitioners can enable positive
outcomes and enhance patient quality of life in a measure that is cost-effective and
simple.
The results of this study provide a basis for constructive and effective social
change in adults residing in the United States who are 18 years and older by
implementing practices that acknowledge and address the connection between VDD and
depression. This study reports ample statistical evidence to suggest an important role for
vitamin D in the incidence of depression. However, demographic characteristics (gender,
age, smoking status, and marital status) were reported not to have a significant role with
the association between vitamin D levels and depression. Consideration of demographic
characteristics (gender, age, smoking status, and marital status) does not statistically
satisfy the criteria of being significantly associated. Therefore, until further
investigations are conducted, determining demographic characteristics (gender, age,
smoking status, and marital status) during screening should not be applied to populations
who are at greater risk for VDD.
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According to Penckofer et al. (2010), prompt detection and effective treatment
when managing vitamin D levels in persons with depressive disorders may be a means to
enhance an individual’s prospective health outcomes and their quality of life. From an
evidence based research perspective, this current study provides empirical understandings
for practice when investigating depression rates stemmed from low levels of vitamin D.
Further, this current study may provide positive social change by strengthening public
health policies and services.
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Appendix A
Tables
Skewness and Kurtosis Statistics
Table 18
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Gender
Skewness

Skew Std.
Error

z-skew

Kurtosis

Kurtosis
Std. Error

z-kurtosis

1.72
0.41

0.07
0.07

23.86*
5.74*

2.68
0.09

0.15
0.15

18.50*
0.64

Female
Depression
1483
1.52
0.06
23.78*
2.02
0.13
Vitamin D
1483
0.43
0.06
6.64*
-0.31
0.13
*Note. Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29)

15.91*
-2.46

Variable

n

Male
Depression
Vitamin D

1140
1140

Table 19
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Age Groups
Variable

n

Skewness

Skew Std.
Error

z-skew

Kurtosis

Kurtosis
Std. Error

z-kurtosis

18-29 years old
Depression
Vitamin D

439
439

1.63
0.49

0.12
0.12

13.89*
4.16*

2.52
-0.11

0.23
0.23

10.80*
-0.45

30-39 years old
Depression
Vitamin D

470
470

1.69
0.39

0.11
0.11

14.99*
3.43*

2.80
-0.22

0.23
0.23

12.44*
-0.96

40-49 years old
Depression
Vitamin D

501
501

1.44
0.52

0.11
0.11

13.25*
4.75*

1.61
0.07

0.22
0.22

7.40*
0.34

50-59 years old
Depression
Vitamin D

428
428

1.54
0.36

0.12
0.12

13.03*
3.07

1.81
-0.39

0.24
0.24

7.68*
-1.65

0.17
0.17

13.80*
-0.78

60 years and older
Depression
785
1.62
0.09
18.66*
2.40
Vitamin D
785
0.38
0.09
4.38*
-0.14
*Note. Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29)
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Table 20
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Smoking
Status
Skewness

Skew Std.
Error

z-skew

Kurtosis

Kurtosis
Std. Error

z-kurtosis

1.45
0.39

0.07
0.07

21.25*
5.79*

1.48
-0.22

0.14
0.14

10.85*
-1.63

Smoke
Depression
1323
1.75
0.07 26.15*
3.29
Vitamin D
1323
0.47
0.07
7.01*
-0.04
*Note. Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29)

0.13
0.13

24.53*
-0.30

Variable

n

Do not smoke
Depression
Vitamin D

1300
1300

Table 21
Skewness and Kurtosis Statistics of the Criterion and Predictor Variables by Marital
Status
Skewness

Skew Std.
Error

z-skew

Kurtosis

Kurtosis
Std. Error

z-kurtosis

1.61
0.33

0.07
0.07

24.78*
5.09*

2.34
-0.16

0.13
0.13

17.98*
-1.20

Married
Depression
1217
1.56
0.07
22.26*
2.04
0.14
Vitamin D
1217
0.59
0.07
8.43*
0.04
0.14
*Note. Distribution was significantly skewed/kurtotic (z-skew/kurtosis > 3.29)

14.57*
0.26

Variable

n

Single
Depression
Vitamin D

1406
1406
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Data Use Agreement

